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Abbreviations 
aa    Amino acid 
AD   Atopic dermatitis 
APC   Antigen presenting cells 
Approx.  Approximately 
BMDC  Bone marrow-derived dendritic cell 
bp    Base pair 
BrdU   5-bromo-2'-deoxyuridine 
CHS   (T cell-mediated) contact hypersensitivity 
CA-MRSA   Community-acquired methicillin-resistant Staphylococcus aureus 
CARD  Caspase-recruitment domain 
CD  Cluster of Differentiation 
DNA    Deoxyribonucleic acid 
DSS   Dextran sodium sulfate 
Fig.    Figure 
FITC   Fluorescein isothiocyanate 
FnBPB   Fibronectin binding protein B 
GALT   gut associated lymphoid tissue 
GlcNAc  N-acetylglucosamine 
h    Hour 
HA-MRSA  Hospital-acquired methicillin-resistant Staphylococcus aureus 
HF  Hydrofluoric acid 
iE-DAP  D-Ȗ-glutamyl-meso-DAP dipeptide+ 
IL  Interleukin 
kb    Kilobase 
kD    Kilodalton 
lip    Lipase 
LPP   Lipoprotein 
MAMP  Microbial-associated molecular pattern 
MALT   Mucosa-associated lymphoid tissue 
MD   Morbus Crohn 
mDC   Myeloid DC 
MDP   Muramyl dipeptide 
MDSC  Myeloid-derived suppressor cell 
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MHC   Major histocompatibility complex 
MM6   Mono-Mac-6 
MSSA   Methicillin-sensitive Staphylococcus aureus 
MurNAc  N-acetylmuramic acid 
NF-țB   Nuclear factor kappa-light-chain-enhancer of activated B cells 
NOD   Nucleotide-binding oligomerization domain 
OD    Optical density 
Ova   Ovalbumin 
PAMP   Pathogen-associated molecular pattern 
PBP   Penicillin-binding protein 
pDC   Plasmacytoid DC 
PGN    Peptidoglycan 
PGNpol  Polymeric wildtype PGN 
PGNpolΔlgt  Polymeric PGN derived from the lgt mutant 
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PRR   Pattern recognition receptor 
SP    Signal peptide 
Spa    Protein A 
Th   T helper cell 
TLR   Toll-like receptor 
TNF   Timor necrosis factor 
TSLP   Thymic stromal lymphopoietin 
UC   Ulcerative colitis 
Vs.   versus 
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Zusammenfassung 
Die Erkennung von Bakterien, wie z.B. von Staphylococcus aureus (S. aureus), durch unser 
Immunsystem wird durch spezielle keimbahn-codierte „pattern recognition receptors“ 
(PRRs) des angeborenen Immunsystems vermittelt. Diese sogenannten Toll-like-
Rezeptoren (TLRs) und NOD-Rezeptoren („Nucleotide-binding oligomerization domain-
containing proteins“) werden fast ubiquitär auf und innerhalb vieler Zelltypen exprimiert, wie 
z.B. Epithel- und Immunzellen. Diese Rezeptoren sind in der Lage unterschiedliche und 
hoch konservierte bakterielle Moleküle zu erkennen, wie z.B. das Lipopolysaccharid (LPS 
über TLR4), Lipoproteine (LPPs über TLR 2/1 und 2/6 TLR) und, basierend auf der Literatur, 
auch das Peptidoglycan (PGN über TLR2, PGN-Fragmente über NOD2), welches den 
Hauptbestandteil der bakteriellen Zellwand darstellt. Das Ziel dieser Arbeit war es die Rolle 
des PGNs in der Aktivierung des Immunsystems und einen möglichen Einfluss auf 
Krankheiten, wie atopischer Dermatitis, Morbus Crohn, ulcerativer Colitis und 
Nahrungsmittelallergien zu eruieren. 
Dazu wurde ein neuartiges Verfahren zur Isolierung von hochreinem PGN in ausreichenden 
Mengen entwickelt und das isolierte PGN und dessen Fragmente, sowie synthetische 
Lipopeptide, in in-vitro-Zellassays getestet. Wir konnten zeigen, dass beispielsweise reines, 
polymeres PGN (> 5mer, PGNpol), isoliert aus einer LPP-defizienten S. aureus SA113-
Mutante (SA113Δlgt), keine Immunantwort und Reifung von dendritischen Zellen (DCs) 
induzierte. Eine Kostimulation von polymerem PGN mit einem TLR2-Liganden, bei dem es 
sich um LPP-Rückstände innerhalb des PGNs aus einem Wildtyp S. aureus (SA113) 
handelte, führte dahingegen zu einem signifikanten Anstieg der IL-6-, als auch der IL-12p40-
Sekretion und der jeweiligen DC-Reifungsmarker (MHC-II, CD40). Eine ähnliche Reaktion 
konnte auch bei der Stimulation einer Monozyten-Zelllinie (Mono-Mac-6-Zellen) und einer 
Makrophagen-Zelllinie (J774-Zellen) beobachtet werden.  
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Nur eine Kostimulation führte zu einer signifikanten IL-8 bzw. TNF-α-Induktion. Ferner führte 
die kutane in-vivo-Applikation von lebenden S. aureus-Zellen bei Mäusen zur Inhibierung 
einer adaptiven Immunantwort durch die Expression von IL-6 und der damit verbundenen 
Rekrutierung Gr1+CD11b+ myeloider Suppressorzellen (MDSCs) an die Infektionsstelle. 
Bedeutender war jedoch, dass die Applikation eines TLR2/6-Liganden (Pam2Cys oder 
diacylierte LPPs), und nicht die Applikation eines TLR2/1-Liganden (Pam3Cys oder 
triacylierte LPPs), zur Migration von MDSCs an den Ort der Infektion führte. 
Diese MDSC-Rekrutierung reduzierte zudem den Grad der mit der Infektion 
einhergehenden Schwellung der Ohren der infizierten Mäuse. Diese Ergebnisse liefern eine 
Erklärung, wie Bakterien in der Lage sein können unsere Haut zu kolonisieren, ohne dabei 
eine Immunantwort zu induzieren. 
Darüber hinaus wurden Ovalbumin-exprimierende Staphylokokken-Stämme (intrazelluläre 
vs. extrazelluläre Expression) kloniert. Dazu wurde ein xylose-induzierbares 
Expressionssystem (basierend auf pTX-Vektoren) genutzt und die resultierenden 
Expressionsvektoren in mehrere Staphylokokken-Stämme transformiert (SA113Δspa, 
SA113Δlgt, SA113ΔoatA, SA113ΔtagO, S. carnosus TM300), welche u.a. in der 
Veränderungen in der Zellwand aufweisen. Die resultierenden Stämme wurden sequenziert 
und die Ovalbumin-Expression durch Western Blot-Analysen unter Verwendung eines 
monoklonalen Anti-Ovalbumin-Antikörpers und eines T-Zell-Proliferations-Assays verifiziert. 
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Summary 
Sensing bacteria, such as Staphylococcus aureus (S. aureus), is based on the ability to 
recognize them via special germline encoded pattern recognition receptors (PRRs) of the 
innate immune system, so called Toll-like receptors (TLRs) and Nucleotide-binding 
oligomerization domain-containing proteins (NODs). These receptors are expressed almost 
ubiquitously on and inside of several cells types, e.g. epithelial and immune cells. They are 
able to recognize distinct and highly conserved bacterial molecules, such as 
lipopolysaccharides (LPS via TLR4), lipoproteins (LPPs via TLR 2/1 and TLR 2/6) and, 
according to previous literature, peptidoglycan (PGN via TLR2, PGN fragments via NOD2), 
which is the main constituent of the bacterial cell wall. 
The aim of this work was to elucidate the role of PGN in activating the immune system and 
to investigate its putative role in diseases, such as atopic dermatitis, Morbus Crohn, 
ulcerative colitis and food allergies. 
Therefore, we developed a new method for isolating highly pure PGN in sufficient amounts 
and tested this molecule and its fragments, along with synthetic lipopeptides, in several in-
vitro cell assays. For instance, we could show that pure polymeric PGN (>5mer, PGNpol), 
isolated from a LPP-deficient S. aureus SA113 mutant strain (SA113∆lgt), did not induce an 
immune response or maturation of murine dendritic cells (DCs). In contrast, co-stimulation 
of polymeric PGN with a TLR2 ligand, namely LPPs residing within the PGN meshwork of 
isolated PGN from a wildtype S. aureus strain (SA113), led to a significant increase in IL-6, 
as well as IL-12p40 and the respective maturation markers (MHC-II, CD40). A similar 
response was observed for stimulation of a monocytic cell line (Mono-Mac-6 cells) and a 
macrophage cell line (J774 cells), where application of PGNpol alone did not induce the 
expression and secretion of IL-8 and TNF-α, respectively.  
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Furthermore, the cutaneous application of S. aureus in-vivo suppressed an adaptive 
immune response by expressing IL-6, which in turn induced and recruited Gr1+CD11b+ 
myeloid derived suppressor cells (MDSCs) to the site of infection. More importantly, 
application of a TLR2/6 ligand (Pam2Cys or diacylated LPPs) elicited the same response in 
vivo, but a TLR2/1 ligand (Pam3Cys or triacylated LPPs) could not achieve the same effect. 
MDSC recruitment also reduced the degree of ear swelling. These findings provide an 
explanation for why and how certain bacteria are able to colonize on our skin without 
inducing an immune response. 
In addition, to clarify a putative role of PGN in inducing allergies, ovalbumin-expressing 
staphylococcal strains (intracellular vs. extracellular expression) have been cloned, using a 
xylose-inducible expression system (staphylococcal pTX vectors). These constructs were 
transformed into several staphylococcal strains (SA113Δspa, SA113Δlgt, SA113ΔoatA, 
SA113ΔtagO, S. carnosus TM300), which differ in their cell wall composition. The resulting 
strains were sequenced and the ovalbumin-expression was verified by westernblot analysis 
using a monoclonal anti-ovalbumin antibody and in T cell proliferation assays. With these 
strains, we will be able to elucidate a putative role of PGN recognition in inducing or inhibiting 
allergic responses in-vitro and in-vivo.  
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General introduction 
1. Staphylococcaceae 
Staphylococci (Greekμ ıĲαφυȜή, staphylē, 
"bunch of grapes" and țόțțος, kókkos, 
"granule") are gram-positive, immotile, non-
sporeforming, facultative anaerobic bacteria, 
and classified under phylum firmicutes (Fig. 1). 
They are mostly catalase-positive and oxidase 
negative with a size between 0.5 to 1.5 µm.  
As their name implies, staphylococci mostly 
occur in “grape-like” clusters. Their genome size varies between 2 – 3 Mb with an average 
GC content between of 33 – 40 mol% (Götz et al., 2006). Staphylococcus aureus (S. aureus) 
SA113 represents an intensively studied catalase-positive strain whose colonies are yellow 
due to the presence of staphyloxanthin. Together with S. epidermidis, it is found in normal 
human skin flora, mostly found in the nasal cavities, where it populates around 80 % of the 
human population (20% long-term and 60 % intermittent carriers) (Kluytmans et al., 1997). 
In healthy adults, this colonization does not cause any problems. However, in some cases, 
such as in immunocompromised patients, S. aureus can cause severe infections e.g., 
osteomyelitis, endocarditis and sepsis. (Lowy, 1998).  
S. aureus utilizes a vast range of molecular tools to colonize on different surfaces, to invade 
host cells and to evade the immune system. These tools include a variety of secreted toxins 
(e.g. enterotoxins, Panton-Valentine leukocidin, hemolysins, toxic shock syndrome toxin 1 
and many more) and enzymes (e.g. proteases, nuclease and hyaluronidases) to lyse and 
disrupt host cells and tissues. Moreover, S. aureus expresses surface-bound adherence 
factors to facilitate extra- and intracellular movement and spreading, such as fibronectin-
binding proteins A and B (FnbpA/B). 
Fig. 1: Clusters of S. aureus, colored electron 
micrograph, Magnitude. ~ 5000x, (source: phil.cdc.gov) 
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Furthermore, S. aureus is a highly adaptable bacterium, as it can change its physiology to 
survive under different unfavorable circumstances; this is achieved by the formation of 
biofilms or the induction of persister cells, so called small colony variants. (Götz, 2002; 
Fedtke et al., 2004; Foster, 2005; Proctor et al., 2006; Veldkamp and van Strijp, 2009).  
In addition, the rise of hospital- or community-acquired Methicillin-resistant Staphylococcus 
aureus (HA/CA-MRSA) infections, caused by highly virulent and multi-reistant strains, is a 
serious, global threat for public health (Deurenberg and Stobberingh, 2009) and underlines 
the importance of intensive studies on staphylococci. 
2. The innate immune system 
The human immune system is a complex molecular and cellular defense machinery that 
protects our bodies from harmful agents, such as bacterial pathogens and it also maintains 
immune homeostasis. It is divided into two parts, the so called innate (nonspecific) and the 
adaptive (or acquired) immune system. The innate immune system acts as the body’s first 
line defense, as it comprises a combination of different physical, chemical and biological 
barriers. It utilizes several specialized cells and mechanisms to attack invading and potential 
pathogenic microorganisms. Its function relies on germline-encoded pattern-recognition 
receptors (PRR), which sense highly conserved molecular patterns made by molecules 
present on the surface of bacteria, fungi or parasites (Medzhitov, 2001). These structures 
or molecules are called Pathogen-associated molecular patterns (PAMPs) or, to be more 
precise, Microbial-associated molecular patterns (MAMPs) (Ausubel, 2005; Didierlaurent et 
al., 2005), which will be introduced in more detail in the next paragraph. The ingestion and 
following presentation of MAMPs by specialized immune cells leads to a subsequent 
expression and secretion of immune modulators, such as chemokines and cytokines (Jr. 
and Medzhitov, 2003), which in turn, orchestrate the adaptive immune system with the aim 
to clear an ongoing infection.
                                                                                           Part I: Introduction 
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Part I: Innate immune sensing of staphylococcal 
peptidoglycan 
Introduction 
3. Toll-like receptorsMicrobial-associated molecular patterns (MAMPs) are very 
important and highly conserved molecules of microorganisms, and can be recognized 
by a variety of PRRs to trigger a subsequent immune response (Akira et al., 2006). 
Therefore, they are considered to be potent inducers of an innate immune response. A 
very important class of PRRs are Toll-like receptors (TLRs), which are highly 
conserved, membrane-associated and non-catalytic proteins found ubiquitously in 
almost all cells from worms, such as Caenorhabditis elegans, up to humans (Janeway 
and Medzhitov, 2002).  
 
Fig. 2: Overview of human Toll-like receptors (Rakoff-Nahoum and Medzhitov, 2008)  
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At present, 12 different TLRs were identified, 10 of them in humans and 12 in mice (Akira et 
al., 2006) and can be surface-bound (TLR1, 2, 4, 5 and 6) or found in intracellular 
compartments, such as endosomes (TLR3, 7, 8 and 9) (Matsumoto et al., 2003; Akira and 
Takeda, 2004), or both. An overview of known TLRs in humans is shown in Fig. 2.  
TLRs consist of a characteristic cytoplasmic Toll-IL-1 receptor (TIR) domain, which is 
important for cell signaling and a cytoplasmic leucine-rich repeats (LRR) domain, 
responsible for ligand binding. Binding of a specific MAMP or ligand to its appropriate TLR 
binding domain initiates a signal cascade, leading to the induction of genes involved in 
innate immune response. These signal cascades involves two different adaptor molecules, 
called myeloid differentiation primary response protein 88 (MyD88) and TIR domain-
containing adaptor protein inducing IFσȕ (TRIF) (Gay et al., 2014). This leads to an 
upregulation of TLR genes, which induces the expression of TLR proteins within the infected 
cell, secretion of pro-inflammatory mediators, such as cytokines and chemokines, and 
antimicrobial peptides (Aderem and Underhill, 1999; Jr and Medzhitov, 2002). These 
molecules will in turn recruit more professional phagocytes and to the site of infection. 
Finally, this results in an inflammation with the five cardinal signs: calor (heat), rubor 
(redness), dolor (pain), tumor (swelling) and function laesa (limited function) (Lucignani, 
2007). There are a multitude of known TLR ligands, such as the well-known 
lipopolysaccharide of Gram-negatives (Hoshino et al., 1999) or flagellin (Gupta et al., 2014), 
the main constituent of bacterial flagella, which is recognized by TLR5.  
Diacylated LPPs from S. aureus are recognized by a heterodimer of TLR2/6, whereas 
triacylated LPPs are recognized by TLR2/1  (Hirschfeld et al., 2001; Akira, 2003). Other 
MAMPs are oligodeoxynucleotides (CpG DNA), single-stranded RNA (ssRNA), double-
stranded RNA (ds RNA) and PGN. The latter is still subject to debate, because of its yet 
unknown minimal structure that binds to the LRR domain of TLR2 and recent papers, which 
could show that PGN is not sensed via TLR2 (Schäffler et al., 2014). 
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In addition, it could be shown that small PGN fragments, such as muramyl dipeptide (MDP) 
are recognized by other intracellular PRRs, namely nucleotide-binding oligomerization 
domain-containing (NOD) proteins (Chamaillard et al., 2003; Girardin et al., 2003).  
4. NOD-like receptors 
Mammalian nucleotide-binding oligomerization domain-containing (NOD) proteins belong to 
the NOD-like receptor family of PRRs and function as cytosolic sensors for innate 
recognition of microorganisms and regulation of inflammatory responses, as well as the 
induction of apoptosis (Inohara and Nuñez, 2003). Therefore NOD ligands have to be 
internalized into the cells by processes like phagocytosis, in order for it to be accessible for 
recognition (Aderem and Underhill, 1999). Two well-known representatives of this protein 
family are NOD1 and NOD2. Both consist of an N-terminal caspase-recruitment domain 
(CARD), a central Nod domain and a C-terminal LRR domain, similar to TLRs. NOD1 and 
NOD2 recognize distinct PGN fragments. NOD1 senses D-Ȗ-glutamyl-meso-DAP dipeptide 
(iE-DAP), which is a fragment of Gram-negative PGN (with some exceptions), whereas 
NOD2 recognizes muramyl dipeptide (MDP), a PGN fragment consisting of MurNAc with its 
lactic acid moiety linked to the N-terminus of an L-alanine-D-isoglutamine dipeptide. This 
structure can be found in almost all bacteria (Chamaillard et al., 2003).  
5. Dendritic cells, Monocytes and Macrophages 
Professional antigen-presenting cells (APCs), like dendritic cells (DCs) play a crucial role 
in activating immune responses. DCs can be divided into two main subsets: cluster of 
differentiation (CD) 11c+ myeloid DCs (mDC) and CD11c- plasmacytoid DCs (pDC) 
(McKenna et al., 2004; Kadowaki, 2007). DCs are considered as so called sentinel cells, as 
their function mainly concerns scanning their environment for non-self antigens or possible 
threats.  
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When a DC detects such an antigen, it is internalized, processed and finally fragments of 
the initial antigen are presented on major histocompatibility complex II (MHC II) molecules 
to naïve CD4+  or CD8+ T cells within the peripheral lymph nodes. After recognition of the 
processed antigens, T cells start to mature and activate other immune cells (in the case of 
CD4+ cells) or kill infected cells (in the case of CD8+ cells)  (Lipscomb and Masten, 2002; 
Shin et al., 2006). Important cytokines, which are produced during this process, are 
interleukin 12 (IL-12) and type I interferons (IFN-α/ȕ). IL-12 acts as a T cell stimulating factor 
that directs T helper cells (Th) towards a Th1 response (amplification of macrophage and 
CD8+ T cell activation) (Hsieh et al., 1993). DCs are also capable of inducing a Th2, such 
as in the presence of thymic stromal lymphopoietin (TSLP) (Kadowaki, 2007).  
Therefore, DCs constitute a major link between innate and adaptive immunity. Another APC 
type is called monocytes, which express the typical marker cluster of differentiation (CD) 
14 and potent producers of tumor necrosis factor alpha (TNF-α) (Ziegler-Heitbrock, 2007). 
They originate, like all cells of the immune system, from a pluripotent hematopoietic stem 
cell and more precisely, from a myeloid progenitor cell. Mature monocytes circulate in the 
blood and recent findings show that there is also a splenic reservoir of monocytes, where 
half of them are stored (Swirski et al., 2009). They migrate to tissues, especially in the case 
of an inflammation, and differentiate into macrophages, as well as DCs, thus replenishing 
the tissue macrophage and DC populations (Gordon and Taylor, 2005). In our studies, we 
used a human monocytic cell line, called Mono-Mac-6 (MM6), which are clones of 
monocytes established from peripheral blood of a patient with monoblastic leukemia  
(Ziegler-Heitbrock et al., 1988) and the J774 murine macrophage cell line (Ralph and 
Nakoinz, 1975).  
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6. Peptidoglycan 
The cell wall of Gram-positive and Gram-negative bacteria differ in its structure and 
composition from one another. Gram-negative bacteria possess an inner and an additional 
outer membrane, which are seperated by the so called periplasm and finally sorrounded by 
a thin peptidoglycan (PGN) layer. This 
layer consists usually of one - three 
molecules and has a thickness 
between 1.5 – 15 nm, whereas the 
cell wall of Gram-positive bacteria 
possess about 30 - 40 layers with an 
overall thickness of approximately 15 
– 30 nm lacking a outer-membrane 
(Vollmer et al., 2007; Silhavy et al., 
2009). The PGN molecule is composed 
of a disaccharide backbone of 
alternating ȕ-(1,4) linked  
N-acetylglucosamine (GlcNAc) and  
N-acetylmuramic acid (MurNAc), both 
D-glucose derivatives. This glycan backbone is additionally cross-linked by a stem peptide 
that consists of five amino acids (aa), while it is synthesized. During the so-called 
transpeptidation reaction, which is catalyzed by penicillin-binding proteins (PBPs), the 
terminal D-alanine is separated to generate the energy needed to connect one stem-peptide 
to the other and hence also the glycan strands. This leads to the formation of a three 
dimensional network (Lovering et al., 2012), which gives the cell its shape and protects it 
from the environment. 
Fig. 3: Schematic structure of muropeptides of S. aureus 
The minimal structure consists of the disaccharide (GlcNAc-
MurNAc) with an adjacent stem peptide (L-Ala – D-iGlx – 
L-Lys/mDap – D-Ala – D-Ala) with Glx being either Gln or Glu. 
Our model organism S. aureus harbors also a pentaglycine 
interpeptide bridge branching from the L-Lys, which constitutes 
indirect cross-links between two adjacent stem peptides, as it is 
depicted in the multimeric muropeptide. (Kühner et al., 2014, 
accepted in Scientific Reports) 
                                                                                           Part I: Introduction 
14 
 
In the case of S. aureus, these aa are L-alanine, D-glutamic acid, L-lysine and D-alanine 
(Fig.3). This tetrapeptide is amidated to the D-lactyl group of MurNAc and additionally cross-
linked via a pentaglycine bridge to ensure stability (BERGERBACHI and TSCHIERSKE, 
1998; Barreteau et al., 2007). Furthermore, S. aureus PGN is also modified at the C6 
position of MurNAc is O-acetylated, which makes the PGN resistant to lysozyme (Bera et 
al., 2005), an enzyme that hydrolyzes the ȕ-(1,4) linkage between MurNAc and GlcNAc. 
7. Inflammatory Bowel Diseases 
Inflammatory bowel diseases (IBD) describe several idiopathic pathological conditions of the 
digestive tract, which belong to the class of autoimmune diseases. Some examples include 
ulcerative colitis (UC), an inflammation of the colon and rectum with an incidence of 24.3 
per 100,000 person-years; another example would be a well-studied disease called Morbus 
Crohn (MD), which affects the whole gut, with an incidence of 12.7 per 100,000 person-
years in Europe (Baumgart and Carding, 2007; Molodecky et al., 2012). There are many 
possible factors, which can lead to a self-reacting gut associated lymphoid tissue (GALT) 
and thus IBD. 
Main factors are most likely, alterations of the gut microbiome (Mukhopadhya et al., 2012) 
and genetic factors (Jostins et al., 2012). For instance, insertion mutations of the PRR NOD2 
do play an important role in the pathogenesis of Morbus Crohn (Hampe et al., 2001).  
At present, there is no cure yet and therapy of IBD is based on immunosuppression to 
alleviate symptoms. Future therapies will utilize a method called fecal microbiota 
transplantation (FMT). In this approach, the microbiota isolated from the feces of healthy 
individuals is transferred to patients. Recent results were quite promising (Aroniadis and 
Brandt, 2013). 
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Aim of this study 
The question, whether PGN is a TRL2 ligand or not, is still discussed. Many papers 
generated clear data strengthening the hypothesis that PGN, or fragments of this 
macromolecule, are not just sensed by NOD-like receptors, such as NOD1 and NOD2, but 
also via TLR2 (Girardin et al., 2003; Chamaillard et al., 2003; Ajuwon et al., 2009; et al., 
2009; Volz et al., 2010; Müller-Anstett et al., 2010). In contrast, Travassos et al. showed that 
sensing of PGN did not occur via TLR2. 
Because of this ambiguity and the fact that most studies used PGN obtained from Sigma-
Aldrich (which is known to be contaminated), we conducted our studies to elucidate, whether 
PGN is certainly sensed by TLR2 or whether the activation of immune cells originates from 
possible TLR2 activation by contaminants, such as LPPs. Therefore, we developed a new 
PGN isolation and analysis method to enable us to isolate sufficient amounts of PGN.  
We were also interested in the consequences concerning the interaction between NOD2 
and TLR2 activation in the context of IBDs. Therefore, we studied the role of NOD2 mediated 
activation of DCs via natural S. aureus derived PGN and investigated the effect of combined 
NOD2 and TLR2 stimulation, compared to single stimulation of the NOD2 receptor alone. 
PGN fragments with a low degree of cross-linking, such as PGN monomers and MDP, have 
been shown to represent natural ligands for the NOD2 receptor (Volz et al., 2010) and even 
cure mice from experimental colitis (Watanabe et al., 2008), implicating an important role in 
the pathophysiology of IBDs. Therefore, we focused on the effect of polymeric 
staphylococcal PGN fragments (named PGNpol) in the activation of the innate immune 
system and additionally investigated the impact of PGNpol recognition in a DSS-colitis 
mouse model. 
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Results 
Basically, there were just two methods so far, which have been used for PGN isolation ever 
since. The first method was developed for the analysis of PGN of Gram-negative bacteria 
(Glauner et al., 1988) and the second method was transferred and adjusted to the thicker 
PGN of Gram-positives (de Jonge et al., 1992). However, these two basic methods are very 
time consuming, utilizing dangerous chemicals (e.g. hydrofluoric acid (HF)) and yield very 
low amounts of PGN (Ø 6 – 8 mg, depending on the volume of the culture). These sample 
limitations also complicated subsequent HPLC analysis of any possible alteration of the cell 
wall pattern during different physiological conditions. For our studies, there was an additional 
need for large amounts of highly pure PGN and its fragments, free of any possible 
contaminant, such as DNA, RNA, LPS and very important, lipoproteins, which are known to 
be TLR2 ligands. (Stoll et al., 2005; Schmaler et al., 2009; Schmaler, 2010). To overcome 
these experimental limitations, we developed a new method for fast isolation and high 
throughput analysis of highly pure PGN. Therefore, we modified the mentioned basic 
methods by omitting unnecessary boiling and centrifugation steps. We replaced ultra-
centrifugation by normal centrifugation and finally, substituted the final 48 h of HF treatment 
for removing wall teichoic acids (WTA) by a simple 4 h hydrochloric acid (HCl) treatment, 
which in turn rendered many subsequent washing steps unnecessary (Paper I: Kühner et 
al., 2014, accepted in Scientific Reports). The large number of omitted washing steps 
enabled us to increase the amount of isolated PGN up to 600 mg from a one liter  
S. aureus overnight culture. Moreover, the whole method was designed for performing in 
Eppendorf cups or even microtiter plates to analyze up to 96 samples in parallel. Next, we 
transferred the subsequent chromatographical procedure to an ultra-pressure liquid 
chromatography (UPLC) system, which firstly reduced the amount of samples and solvents 
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and secondly, the total time of analysis by the factor of 2,5 (70 minutes vs. 180 minutes).  
To prove our method, we isolated PGN of several species, e.g. S. aureus and E. coli, and 
digested it with mutanolysin or lysozyme, respectively. The muramidases mutanolysin and 
lysozyme are used to cleave the ȕ-(1,4)-glycosidic bonds within the glycan backbone,  
 
Fig. 5: Muropeptide profile of E. coli Nissle 1917 after lysozyme digestion obtained by UPLC 
Masses of indicated peaks are shown in table 2 (paper I, p. 52) including molecule composition and sum 
formula. 
 
Fig. 4: Muropeptide profile of S. aureus SA113 after mutanolysin digestion obtained by UPLC 
Masses of indicated peaks are shown in table 1 (paper I, p. 52) including molecule composition and sum 
formula. 
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resulting in the expected, species specific muropeptide pattern, as well as the appropriate 
molecular masses (Fig.4 and 5). O-acetylation, a modification of the C6 atom of MurNAc 
confers lysozyme resistance to pathogenic staphylococcal strains (Bera et al., 2005; Bera 
et al., 2006). This modification was thought to be removed during the final acidic treatment 
of PGN isolation. We analyzed HF treated PGN and compared it to HCl treated PGN and 
obtained the same muropeptide pattern. Strikingly, our data showed, for the first time, that 
most of the satellite peaks, as well as some of the peak shoulders, were in fact still O-
acetylated (Fig.6 and table S1 of paper I). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Comparison of isolated peptidoglycan treated with HCL and HF 
Muropeptide pattern of peptidoglycan of S. aureus SA113 treated with either HCl (a) or HF (b). The HF treated 
muropeptide pattern shows no differences compared to the HCl treated one. O-acetylated fragments listed in 
paper I, table S1, p. 62-65 
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Next, we upscaled our method from ultra-pressure liquid chromatographic (UPLC) to 
analytical and finally preparative HPLC dimensions. This upscaling procedure enabled us to 
isolate sufficient amounts of PGN fragments for further testing in in-vitro cell assays.  
We decided to investigate PGN of wildtype (WT) S. aureus SA113 and its available 
lipoprotein diacylglyceryl transferase (lgt) deletion mutant (SA113Δlgt). Monomeric (Fig. 7B) 
up to polymeric PGN (PGNpol, Fig. 7A) fragments of both strains were collected and 
desalted, their molecular masses verified via MS and each sample was additionally tested 
prior and after lyophilization for LPS contamination, because LPS, as potent immunogenic 
molecule, might induce false positive results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Monomer: m/z 1253.7= [M+H]+ B 
Fig. 7: Separation and analysis of PGN fragments of S. aureus SA113Δlgt by HPLC. The box indicates 
collected PGNpol, B The arrow indicates the desalted monomeric PGN fragment withits appropriate molecular 
weight determined by MS.
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To address the initial question, whether PGN is a TLR2 ligand or not, we stimulated 1 x 106 
bone marrow-derived DCs (BMDCs) with different amounts of pure monomeric up to 
pentameric PGN fragments for their immunogenic capacity in DCs, MM6 and J774 cells and 
observed no induction of IL-6, IL-12p40, IL-8, and TNF-α, respectively (data not shown). 
The same was true for PGNpol derived from SA113Δlgt (PGNpolΔlgt). In contrast, stimulation 
of DCs with PGNpol derived from the wildtype strain induced a very high and significant signal 
for IL-6 and IL-12p40 (Fig. 8). We stimulated BMDCs with PGNpol of both strains and 
analyzed maturation markers using flowcytometry (FACS) and indeed, we could observe,  
 
as expected, a significant increase in specific DC maturation markers, namely major 
histocompatibility complex II (MHCII) and the costimulatory protein CD40, in the case of 
stimulation with WT PGNpol, but not with PGNpolΔlgt. (Fig. 9). Because of these findings, we 
decided to focus on PGNpolΔlgt for further experiments. 
 
Figure 8: Stimulation with PGNpol, but not with PGNpolΔlgt, leads to a significant secretion of IL-6 
and IL-12p40 in DCs 
Incubation of DCs with PGNpol but not with PGNpolΔlgt stimulates IL-6 (A) and IL-12p40 (B) secretion, which 
is comparable to that induced by LPS or Pam3Cys. DCs are stimulated with PGNpolΔlgt up to a concentration 
of 100 µg/ml. Stimulation with 10 µg/ml PGNpol leads to a high secretion of IL-6 and IL-12p40. Comparison 
was made between unstimulated cells and each stimulant using a nonparametric one-way ANOVA model for 
repeated measurements with a Bonferroni adjustment. 
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Interestingly, induction of IL-6 and IL-12p40 in BMDCs, as well as the induction of maturation 
markers, was abolished in BMDCs derived from NOD2-deficient mice, but only when 
stimulated with WT PGNpol. This striking observation strongly indicates a clear synergistic 
effect of PGNpol as NOD2 ligand and remaining LPPs within the polymeric PGN meshwork, 
acting as TLR2 ligand. The same pattern was observed for respective maturation markers 
(Fig.10 and 11). 
To prove our hypothesis of a putative synergistic NOD2/TLR2 effect, we stimulated BMDCs 
either with PGNpolΔlgt, Pam3Cys, which resembles a triacylated LPP, or a combination of 
these two ligands. As expeted, combinatorial stimulation of with PGNpolΔlgt with Pam3Cys led 
to a significant increase in all tested cytokines (Fig.12). These experiments revealed 
synergistic effects on IL-12p40 and TNF-α secretion (an early response cytokine), but not 
on IL-6 secretion pattern. 
 
Figure 9: Stimulation with PGNpol, but not with PGNpolΔlgt, leads to an increased MHC class-II and
CD40 expression in DCs 
Immature BMDCs were activated with several NOD2 or TLR2 ligands. Maturation was quantified by FACS 
analysis assessing the levels of MHC class-II (A) and CD40 (B). The quantification was used based on isotype 
controls. Stimulation of DC with PGNpol 10 µg/ml leads to a strong signal of MHC class-II and CD40. In 
contrast, stimulation of DCs with PGNpolΔlgt 10 µg/ml does not lead to an increased expression of MHC class-
II and CD40. Comparison was made between unstimulated cells and each stimulant using a nonparametric 
one-way ANOVA model for repeated measurements with a Bonferroni adjustment. 
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Figure 10: Stimulation with PGNpol in DCs is dependent on a NOD2 co-stimulus 
Stimulation with PGNpol leads to a significant increased secretion of IL-6 (A) and IL-12p40 (B) in DCs from WT mice 
compared to unstimulated controls. In contrast, DCs derived from NOD2-/- mice failed to induce IL-6 and IL-12p40 
secretion upon stimulation with PGσpol. DCs from stimulated WT mice were compared to unstimulated DC’s from WT 
mice. Respectively, DC’s from stimulated NOD2-/- mice were compared to unstimulated DC’s from στDβ-/- mice. 
Figure 11: DC stimulation with PGNpol in WT mice leads to an increased expression of MHC class-II and CD40 
compared to NOD2-/- mice 
Stimulation of DCs from NOD2-/- mice with PGNpol 10 µg/ml did not lead to a significantly higher expression of MHC 
class-II (A) or CD40 (B), indicating that the co-stimulatory effect of NOD2 and TLR2 is necessary for effective 
maturation of DCs. Stimulated DCs from WT mice were compared to unstimulated DCs from WT mice, and 
unstimulated DCs from NOD2-/-mice were compared to stimulated DCs from NOD-/- mice. In addition, a comparison 
between DCs from WT and NOD2-/- mice was made by using a nonparametric one-way ANOVA model for repeated 
measurements, with the Bonferroni adjustment.. 
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To further substantiate these findings, we repeated our stimulation experiments with 
additional immune cells and could confirm our data in a human monocytic cell line (MM6, 
IL-8 secretion), as well as a murine macrophage cell line (J774, TNF-α secretion) (see Fig. 
7 and 8, paper II).  
 
 
 
Figure 12: Combined stimulation of DCs with a NOD2 and TLR2 ligand leads to a stronger secretion of 
IL12p40 and TNF than stimulation with each of the stimuli alone 
DCs were stimulated with PGNpolΔlgt 10 µg/ml, Pam3Cys 1 µg/ml and LPS 1 µg/ml. 
After stimulation with both ligands, PGNpolΔlgt and Pam3Cys, there was a significant higher signal of IL12p40 (A) 
and TNF (C) compared-α to stimulation with the single components alone. There was not a significantly higher 
signal of IL6 compared to stimulation with the single components (B). Unstimulated DCs from WT mice were 
compared to stimulated DCs from WT mice using a nonparametric one-way ANOVA model for repeated 
measurements with a Bonferroni adjustment.  
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Next, we were interested in how these signaling events could be interpreted within the 
context of IBD. Therefore, a possible protective effect, as described in Watanabe et al., 
2008) for MDP, of intraperitoneal PGNpol administration was studied in a murine DSS colitis 
model. Acute colitis was induced by 3.5 % dextran sodium sulfate (DSS) in C57BL/6 (WT) 
and NOD2-/- mice and 100 µg PGNpol was administered intraperitoneally every third day. 
Mice were grouped in three categories:  
 
1. WT or NOD2-/- mice + PGN administration + DSS  
2. WT or NOD2-/- mice + PBS administration + DSS  
3. WT or NOD2-/- mice + PGN administration 
 
After a seven-day treatment with 3.5 % DSS in the drinking water, C57BL76 and NOD2-/- 
mice showed signs of acute colitis with weight loss and bloody diarrhea. The two groups did 
not differ significantly between their colon weight and length and NOD2-/- mice had a 
statistically significant trend towards less weight loss compared to C57BL/6 mice (Data not 
shown)  
To further address the function of NOD2 activation, we studied the effect of intraperitoneal 
administration of either PGNpol or PGNpolΔlgt in a murine colitis model. Unfortunately, both 
polymeric PGN types did not lead to a similar protective effect (Fig. 13), as it was shown for 
MDP. Because of a missing relevance, we did not add these results to our final publication. 
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Figure 13: Effects of intraperitoneal PGNpol administration in a DSS colitis mouse model 
C57BL/6 (WT) and NOD2-/- mice were treated with 100 µg solved PGNpol every third day and sacrificed 
at day seven. Mice were analyzed for different disease symptoms. This figure shows and induced weight 
loss over time in DSS mice, but no protective effect. 
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Discussion 
DCs are the most important immune cell type, linking innate immunity with downstream 
adaptive immunity and thereby taking over a very important role in the Mucosa-associated 
lymphoid tissue (MALT) (Cella et al., 1997), intestinal homeostasis, and Morbus Crohn. 
NOD2 is a well-studied PRR, sensing diverse PGN fragments, such as MDP, monomeric 
and polymeric PGN (Volz et al., 2010; Iyer and Coggeshall, 2011) activating the transcription 
factor NF-țB (Strober et al., 2008). Insertion mutations within the caspase recruitment 
domain 15 (CARD15) of the NOD2 correlate with an increased susceptibility to Morbus 
Crohn (Hampe et al., 2001), but it is still unclear, why this mutation may trigger chronic 
intestinal inflammations.  
Until now, several publications addressed the complex interplay between NOD2 and TLR2 
signaling events, which might have an influence on intestinal homoeostasis. Synergistic 
effects of PRR sensing on the release of cytokines, such as IL6 and IL12p40 in stimulated 
BMDCs, being abolished in NOD2-/- cells, were shown by a study of Magalhaes et al. in 
2008. Other studies characterized anti-inflammatory effects of sensing PGN derived from 
specific lactobacilli species, being crucial for the probiotic effect of these strains (Macho 
Fernandez et al., 2011), as well as protective effects of NOD2 activation by MDP in 
experimental colitis mice models (Watanabe et al., 2008). These studies further support the 
hypothesis that activation of NOD2 seems to play a minor role in activating immune cells  
– in contrast to co-stimulation of NOD2 and TLR2 – but might lead to a downregulation of 
inflammatory pathways and thereby suppressing immune responses against harmless or 
even beneficial microbes. A “loss-of-function” in the στDβ gene might therefore be an 
important part in the pathogenesis of Morbus Crohn. 
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In our study, stimulation of DCs, and other immune cells, with the sole NOD2 ligand 
PGNpolΔlgt does not lead to a significant NF-țB-depending immune response, but 
additional stimulation with a TLR2 ligand was needed to induce such a response, leading to 
the secretion of several distinct cytokines (IL-6, IL-8, IL-12p40, TNF-α).  
In summary, we could showed that the concept of synergistic amplification of PRR signaling, 
in our study activation of NOD2 and TLR2 PRRs and their respective signaling pathways, 
represent an important concept for modulating immune responses and the maintenance of 
immune homeostasis in the gut. According to our data, pure PGN molecules do not induce 
a significant immune response via TRL2 activation, unless a co-stimulation via NOD2 
occurs, which subsequently result in a potent activation of DCs, macrophages, as well as 
monocytes. Our data are contrary to data obtained by Müller-Anstett et al. (2010), where a 
co-localization of pure and biotinylated PGNpol led to IL-1ȕ, IL-6 and TNF-α secretion and 
NF-țB activation. Our data are important for a better understanding of the complex interplay 
between these receptors in maintaining homeostasis of the intestinal immune system. 
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Part II: Adaptive immune response against staphylo-
coccal lipoproteins in the context of atopic dermatitis 
Introduction 
8. Adaptive immunity 
The second main part of our immune system is called the adaptive immune system, which 
has evolved in vertebrates to beis activated by signals of the innate immune system. 
The adaptive immune system comprises of specialized immune cells, namely B and T cells, 
that specifically react against processed antigens. In contrast to the quite unspecific innate 
immune system, antigen specific receptors are deployed to recognize microbial antigens. 
These non-germline-encoded receptors, B cell receptors (BCR) and T cell receptors (TCR), 
are produced in a process called somatic or V(D)J recombination  
(Li et al., 2004; Litman et al., 2010). This genetic recombination process generates a vast 
repertoire of antigen specific BCR and TCR assuring the detection of almost every intruding 
antigen. According to their origin, B cells are named after the bone marrow and T cells after 
their place of maturation: the thymus.  
After recognizing an antigen presented by APCs via their B cell receptor (BCR), B cells 
secrete a soluble form of the same receptor, the so-called immunoglobulins or antibodies 
(Harwood and Batista, 2010). Antibodies in turn activate the complement system, a part of 
the innate immune system comprising of several serum proteins. These proteins, amongst 
others, opsonize pathogens by binding to their surface or deactivate toxins (Ravetch and 
Bolland, 2001).  A striking feature of the adaptive immune system is its immunological 
memory, based on plasma B and memory T cells. This hallmark of the immune system 
provides a more rapid and more potent response to a second infection with the same 
pathogen (Kassiotis et al., 2002; Zinkernagel et al., 2003; Sallusto et al., 2010). 
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Because of its importance, disorders in the normal and highly complex function of the 
immune system can lead to fatal diseases, like autoimmune disorders (e.g. inflammatory 
bowel diseases), cancer (τ’Byrne and Dalgleish, β01γ) or allergies. 
9. Lipoproteins 
Lipoproteins (LPPs), as a part of the bacterial cell envelope, are proteins containing a lipid 
moiety, which are covalently linked to an N-terminal cysteine residue. This lipid moiety is 
anchored to the outer leaflet of the cell membrane .S. aureus expresses about 50 LPPs with 
mostly unknown functions. However, it has been established that they can act as ATP 
binding cluster (ABC) transport systems as demonstrated by SitC, as oligopeptide permease 
(OppA), peptidyl-prolyl cis/trans isomerase (PrsA) or a thiol-disulfide oxidoreductase activity 
(DsbA) (Schmaler et al., 2010). 
The biosynthesis of LPPs involves two steps: the first step is catalyzed by the phosphatidyl 
glycerol diacylglyceryl transferase (Lgt). This enzyme transfers a diacylglyceryl group from 
phosphatidylglycerol to a cysteine residue within a conserved sequence, called the lipobox, 
forming a thioether linkage. A specific signal peptide leads this pre-lipoprotein to the Sec 
machinery, where it get cleaved by a lipoprotein-specific type II signalpeptidase (LspA) 
(Schmaler et al., 2010). However, it is still debated, if S. aureus LPPs are di- or triacylated, 
as it is the case in Escherichia coli. In Gram-negatives, LPPs are mostly modified in a third 
step by an N-acyltransferase that transfers a third N-acyl group to the pre-mature lipoprotein 
(Kurokawa et al., 2009). In addition, LPPs play a fundamental role in innate immune 
recognition processes. Diacylated LPPs are recognized by Toll-like receptors (TLRs) 2/6, 
whereas triacylated LPPs are recognized by TLR 2/1. This recognition induces a subsequent 
immune response and leads to the secretion of interleukin 6 (IL-6) and tumor necrosis factor 
alpha (TNF-α) (Stoll et al., 2005). 
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Aim of this study 
The human skin represents a very important organ with a large outer surface. It acts as a 
physical barrier and the site of first contact to a variety of microbes, thereby orchestrating 
innate, as well as consecutive adaptive immune responses. S. aureus, as described in the 
General Introduction section, is a natural commensal, but also one of the most potent skin 
pathogens. Because more than 90% of atopic dermatitis (AD) patients are colonized with  
S. aureus, there is a need to understand the skin-driven immunity better. 
To elucidate the underlying molecular mechanisms of this phenomenon, we used different 
mice models (WT, TLR2-/- and IL6-/- BALB/c mice), combined with a murine T cell-mediated 
contact hypersensitivity (CHS) to fluorescein isothiocyanate (FITC), and infected these 
sensitized mice with S. aureus Newman and its lipoprotein-deficient Δlgt mutant. In addition, 
defined lipopeptides (synthetic fatty tails of lipoproteins) were applied cutaneously using the 
same mice models. We investigated ear swelling, activation of several immune cells, such 
as T cells and MDSCs, as well as IL-6 expression and secretion. 
In the following section, the intriguing results of this study will be presented and discussed. 
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Results 
To characterize skin-driven immunity, WT S. aureus Newman and its respective lipoprotein-
deficient mutant NewmanΔlgt were applied cutaneously in order to mimick colonization or 
an infection of the skin with a Gram-positive bacterium. To investigate why and how this 
colonization or infection of the skin influences subsequent immune responses, mice pre-
sensitized to FITC were infected with 3 x 108 cells at defined time points, as shown in  
Fig. S1. 
 
Infection with WT bacteria, in contrast to its isogenic Δlgt mutant, significantly reduced ear 
swelling, the main symptom of induced dermatitis in mice (Fig. 14 B and C). This striking 
result can be explained with alterations in specific immune cell populations, such as a 
reduced FITC-specific T cell proliferation in skin-draining lymph nodes (Fig. 14 D), reduced 
numbers of CD4+ and CD8+ T cells in the spleen with a respective increase in Gr1+CD11b+ 
MDSCs (Fig. 14 E). These findings gain an aditional clincal relevance in AD patients, where 
most patients carry staphylococci and exhibit an increase in MDSC numbers in PBMCs (Fig. 
14 F). 
Protocol of FITC-CHS with and without cutaneous exposure to S. aureus or TLR ligands. 
Wild-type (WT) mice were sensitized by administration of FITC solution on the shaved abdomen on days -8 and -7. 
Together with the second application of FITC on days -1 and 0, some mice were epicutaneously exposed to living WT or 
lipoprotein deficient (Δlgt) S. aureus or TLR ligands in addition. Control mice obtained phosphate-buffered saline (PBS). 
As read out for the cutaneous recall immune response, FITC was applied to the previously untreated ear skin on day 7 
and the increase of ear thickness (ear swelling) was measured over a period of 3 days. 
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Figure 14: Cutaneous Staphylococcus aureus Induces Immune Suppression in mice and humans 
FITC-sensitized WT BALB/c mice were treated either with living WT S. aureus Newman or its lipoprotein-deficient 
mutant (Δlgt), ear swelling (mean ± SD, n = 5) histology (H&E staining) (B), percentage of cell populations in the 
spleen (mean ± SD, n = 5) (E) were investigated. *p < 0.05., (F) PBMCs from atopic dermatitis (AD) patients (n = 33) 
and healthy volunteers (n = 30) were analyzed for MDSCs, defined as CD11b+CD33+HLA-DRÀCD14À cells. 
The dots represent individual values, and the horizontal bar is the group mean. Red squares represent MDSCs of 
patients with severe AD and eczema herpeticum. 
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These data clearly indicate an immunosuppressive effect of cutaneous  
S. aureus application, which is triggered by the induction of MDSCs. The inability of SA113 
Δlgt to induce immune suppression was a clear explanation for the induction of immune 
suppression by the recognition of LPPs. Together with the fact that LPPs are sensed 
differently via heterodimers of TLR2/1 (triacylated) or TRL2/6 (diacylated) (Henneke et al., 
2008), this led to our hypothesis that sensing of either diacylated or triacylated LPPs must 
be the cause of this immune reaction. To investigate this, we decided to repeat the same 
experiments and cutaneously applied synthetic molecules named FSL-1, Pam2Cys and 
Pam3Cys, resembling di- and triacylated fatty tails of LPPs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Cutaneous Exposure TLR2-6 but Not TLR2-1 Ligands Ameliorates T Cell-Mediated Recall
Responses of the Skin 
WT MBALB/c mice were cutaneously exposed to Pam2Cys or Pam3Cys. Ear swelling response (mean ± SD, n = 5) 
(E), histology (H&E staining) (F), proliferation of skin-draining LN cells stimulated ex vivo with FITC (mean ± SD of 
triplicates) (G), and the percentage of cell populations in the spleen (mean ± SD, n = 5) (H) are shown. 
Data are representative of at least two independent experiments. Experiments shown in (A) were performed with FSL-
1 from two different providers. *p < 0.05. 
                                                                                                  Part II: Results 
34 
 
As shown in Fig. 16 E and F, cutaneous application of Pam2Cys (also FSL-1, Fig. 2 A - D 
of paper III), but not Pam3Cys, led to a decrease in ear swelling, a reduction in T cell 
proliferation (Fig. 14 G), as well as a siginificant increase in Gr1+CD11b+ MDSCs. Depletion 
of Gr1+ cells abolished immune suppression, which could be restored by adoptive transfer 
of MDSCs (previously exposed to Pam2Cys) (Fig. 3 A of paper III). Furthermore, treatment 
of Tlr2-/-  mice with Pam2Cys showed no decrease in ear swelling, T cell proliferation and no 
increase in Gr1+CD11b+ MDSCs (Fig. 14 A - C). These results indicate a clear TLR2-
dependancy of immune suppression by diacylated lipopeptides/LPPs, such as Pam2Cys. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Pam2Cys-Induced Immune Suppression Is Dependent on TLR2 
WT and Tlr2-/-  mice were treated following the protocol shown in Figure S1A and ear swelling (mean ± SD, n = 5) after 
FITC challenge (A), proliferation of lymph node cells after FITC stimulation ex vivo (mean ± SD of triplicates) (B), 
and the percentage of spleen cell populations (mean ± SD, n = 5) (C) were analyzed. 
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Discussion 
Our skin, constantly exposed to and colonized by a vast number of bacteria, estimated as 
10 times the amount of somatic cells (Costello et al., 2009), Cutaneous innate immune 
sensing plays a key role in skin-related immune homoestasis and the control of subsequent 
adaptive immune responses in infections. In this study, cutaneous exposure to bacteria and 
bacterial MAMPs induced a strong immune suppression, which was mediated by MDSCs. 
These results highlight the ability of certain MAMPs to act as immunosuppressive agents, 
controlled by the activation of specific signaling pathways to evade the immune system. 
We characterized these signaling properties and showed that cutaneous exposure to TLR2-
TLR6, but not to TLR2-TLR1, ligands induced skin-resident MDSCs and consecutive 
cutaneous immune suppression. Bacterial LPPs differ in their acylation patterns, which in 
turn depend on environmental factors and growth phases. SitC, a well-known LPP from  
S. aureus, was shown to be triacylated, when the cells were in the exponential growth phase 
at neutral pH and diacylation occurring at acidic pH values. (Kurokawa et al., 2012; 
Kurokawa et al., 2012). With this knowledge, we could assume that LPPs might also differ 
in their TLR2 activation potential. As a result, acylation properties might characterize 
bacteria living on the skin, as pathogens or commensals. In addition, the pH of our skin is 
low and chronic S. aureus colonization is present in almost all AD patients, assuming S. 
aureus being in an exponential growth phase. Therefore, LPPs from S. aureus on the skin 
might be more diacylated. Together with our data and data published by Kaesler et al. 
(2014), which could identify TLR2 ligands as promoters for AD through IL4-mediated 
suppression of IL-10, we proposed following model, illustrated in Fig. 17. 
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Diacylated lipopeptides present on the surface of S. aureus, activate TLR2-6 presented on 
skin resident cells, followed by increased IL-6 production leading to MDSC recruitment to 
the site of infection. This accumulation of MDSCs is a prerequisite of subsequent immune 
suppression and inhibition of a subsequent adaptive immune response. 
In summary, we could identify an ingenious immune evasion mechanism triggered by  
S. aureus. These infections recruited MDSCs to the site of infection by modulating the 
acylation pattern of surface LPPs, which in fact led to immunosuppression. Our study nicely 
shows a direct link of cutaneous innate immune sensing with adaptive immune functions. 
The presence bacteria on the skin with specifically acylated LPPs is able to counter regulate 
inflammation and suppress immune responses. 
 
 
Figure 17: Model of skin-infecting S. aureus caused immune suppression 
Diacylation of stpahylococcal LPPs causes immune suppression by recruiting MDSCs via TLR2-depending induction of 
IL-6 
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Part III: The role of PGN in the development of food 
allergies in humans 
Introduction 
10. Allergies 
In general, allergies are defined as hypersensitivity disorders, which are overreactions of 
our immune system against usually harmless antigens. This hypersensitivity leads to 
symptoms, such as eczema, itchiness, nausea, vomiting, but can also lead to a severe 
anaphylactic shock and death. Causes of allergies are very diverse and include, in particular, 
environmental factors, such as pollution and excessive usage of antibiotics or other 
chemicals in the food industry, a genetic predisposition and classical food-allergens, such 
as proteins derived from hen eggs, milk, fish and peanuts (Swert, 1999). The highest risk to 
develop an allergy is at young ages (Croner, 1992) and several studies showed a correlation 
between the antibiotic application in infants and an increasing incidence of allergic diseases 
(Droste et al., 2000).  
These disorders are divided mainly into four types (after Gell PGH, Coombs RRA, eds. 
Clinical Aspects of Immunology. 1st ed. Oxford, England: Blackwell; 1963): 
1. Type I hypersensitivity (or immediate) 
2. Type II hypersensitivity (or cytotoxic) 
3. Type III hypersensitivity (immune complexes) 
4. Type IV hypersensitivity (delayed type hypersensitivity) 
Food allergies belong to type I hypersensitivities, representing classical IgE-mediated 
immune reactions and has to be distinguished from food intolerances based on their 
pathophysiology and cause. The initial recognition of an antigen or allergen,  
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such as ovalbumin (ova, the main protein found in egg white), results in the activation and 
maturation of naïve CD4+ Th cells to Th2 cells. This cell type produces IL-4 and interacts with 
B cells. This interaction acts in concert with IL-4 and results in production of IgE antibodies. 
This type of antibodies is able to binds its receptor FcεRI on basophilic granulocytes as well 
as mast cells. This first contact to an allergen is called acute response and results in 
sensitized, IgE-coated cells. During a later exposure, the same allergen, can bind to these 
sensitized cells, thereby cross-linking IgE antibodies and FcεRI receptors. This process 
leads to a degranulation and subsequent release of immune mediators, such as histamine 
and others, which in turn leads to classical allergic symptoms, as described before. 
Aim of this study 
There are several studies indicating the importance of the intestinal microbiota in preventing 
several diseases, amongst others food allergies. Furthermore, application of antibiotics, 
such as Penicillin (a ȕ-lactam antibiotic, which inhibits PGN assembly) in early childhood 
alters the composition of this microbiota, which in turn may lead to an increased risk of 
asthma and allergies (Droste, Wieringa, Weyler, Nelen, et al., 2000). Moreover, the 
occurrence of Staphylococci in infant gut microbiota correlates with an increased risk of 
developing atopic AD (Vael and Desager, 2009). Because of these findings, we 
hypothesized that inhibition of PGN assembly by ȕ-lactam antibiotics, leading to cell lysis, 
could increase the number of available PGN fragments within the gut. This multitude of 
fragments, such as monomers, dimers, etc., could be easily uptaken through the infantile 
gut barrier, which is leakier than in adults (Järvinen et al., 2013). These uptaken fragments 
are presented to intestinal DCs (Rescigno, 2014) with could finally lead to the subsequent 
development of a misguided immune reactions against these fragments and consequently 
to a food allergy. 
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To prove our hypothesis, we constructed two different avian ovalbumin (the major allergen 
of hen egg white) expressing staphylococcal vectors and transformed them into different 
staphylococcal strains: The first constructs encodes for ovalbumin, which is secreted to the 
culture supernatant, due to the presence of a signal peptide, whereas the second constructs 
facilitated the intracellular expression of ovalbumin. These constructs, bringing together a 
model allergen and a main bacterial constituent in a spatial and temporal manner, enables 
us to investigate the impact of PGN signaling via pathways of the innate immune system, 
on the pathophysiology of food allergies.  
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Results 
A codon usage optimized, synthetic avian ovalbumin (ova) gene (SERPINB14, from Gallus 
gallus, NCBI gene ID: 396058, size: 1161 bp) 
containing restriction sites for SalI, XhoI and 
EcoRI, was ordered from GeneArt 
(LifeTechnologies, Darmstadt). The carrier 
plasmid pMK was transformed into E. coli 
DH10B, which possesses particularly useful 
properties, such as a high transformation 
efficiency, the ability to take up and stably 
maintain large plasmids and the lack of 
methylation-dependent restriction systems 
(MDRS) (Durfee et al., 2008). Isolated plasmid DNA was digested either with XhoI/EcoRI or 
SalI/EcoRI to generate compatible ends for ligation into plasmids pTX-yfp-mreB and pTX-
mch-cw, respectively (pTX30 derivatives, containing fluorescent proteins Yfp and Mcherry, 
kindly provided by Wenqi Yu). Both constructs were ideal for achieving the mentioned goals 
of secreting vs. intracellular expression: pTX-mch-cw harbors sequences encoding a signal 
peptide (SP, containing an YSIRK motif) and a propeptide (PP, derived from a lipase of S. 
hyicus) upstream of a gene of interest. The SP facilitates secretion of proteins and the PP 
is thought to function as an intramolecular chaperone (Sturmfels et al., 2001). Indeed, a first 
attempt to clone a construct for intracellular expression of ovalbumin failed due to the lack 
of this PP (see Fig. 18, construct (2)). 
 
 
 
Figure 18: 3D model of avian ovalbumin 
© RCSB Protein Data Bank 
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Cloning the ovalbumine gene downstream of these important genetic elements (see Fig. 18, 
construct (1 and 3)) was successful, verified by restriction analysis and sequence analysis 
of the resulting plasmids pTX-sp-pp-pva (for the secreted version) and pTX-pp-ova 
(intracellular version) by GATC (Konstanz), including its promotor. In contrast to construct 
2, the other constructs led to a stable expression of ovalbumine, when transformed 
staphylocooci were induced at an OD of 0,6 - =0,7 with 0.5 % xylose and subsequently 
grown for at least 16 - 24 h in Brain Heart Infusion (BHI) medium at 37°C under shaking 
conditions (160 rpm). Successful expression was verified after isolating whole protein 
fractions of lysed cells and their respective supernatants by semi-dry western blot analysis 
using monoclonal mice anti-ovalbumin antibodies (ab) (Abcam, Cambridge, UK). 
Representative western blots of a protein A-deficient SA113 strain (SA11γΔspa), which lead 
to a decrease in background signals due to a lesser extent of unspecific binding of the ab to 
other remaining proteins on the blot, are shown in Fig.19 A and B.  
 
Figure 19: Overview of the assembled ovalbumin expression constructs 
Peptides, their respective sizes and successful expression are indicated. 
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Native ovalbumin has a molecular weight of approx. 45 kilodaltons (kDa) and always 
appeared as double band, which originates from a degradation during sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The propeptide-ovalbumin fusion 
protein (named PP-OVA) has a size of 573 aa. Taken the average mass of an amino acid 
as 137 Da (calculated according to data from Promega (Mannheim)) PP-OVA should have 
a theoretical mass of 78,5 kDa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Ovalbumin expression in SA113Δspa after 24 hours 
Ovalbumin was isolated from the supernatant (A) of the same induced and lysed cells (B), respectively. 
For detection, a nitrocellulose membrane was incubated with a primary monoclonal mice anti-ovalbumin 
antibody. M: Marker; Ova: positive control with ovalbumin (Hyglos, Bernried); Δspa: negative control 
SA113Δspa; PP-OVA: propeptide-ovalbumin fusion protein; - and + indicates xylose induction 
A 
B 
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However, migration of isolated ovalbumin was observed at around 100 kDa. The reasons 
for such “gel shiftings” are still poorly understood. Potential protein glycosylation events, 
post-translational modifications or changes in detergent binding could explain this migration 
behavior, which was shown for transmembrane segments of membrane proteins, as well as 
cytosolic proteins (Rath et al., 2009; Shi et al., 2012).  
Outlook 
Currently, we are working on the additional validation of ovalbumin expression and 
secretion, utilizing a T cell proliferation assay based on bromodeoxyuridine (BrdU) 
incorporation during DNA synthesis in replicating cells. For our purposes, we are using an 
assay based on the proliferation of CD4+ T cells derived from transgenic mice, providing 
ova-specific T cell receptors. First results are quite promising, indicating a clear ovalbumin-
specific proliferation, when xylose-induced (ovalbumin containing) supernatants of 
SA11γΔspa pTX-sp-pp-ova overnight cultures were applied onto a co-culture of 2 x 105 
CD4+ T cells with 3.8 x 105 APCs in the presence of undiluted supernatants (Fig. 21).  
In contrast, stimulation with intracellular ovalbumin-expressing cultures (SA11γΔspa pTX-
pp-ova) did not lead to a significant difference in T cell proliferation. A possible explanation 
is the fact that not all T cells derived from transgenic mice are in fact specific. The number 
of ova-specific T cells is estimated between 60 – 80 % of total T cells. This, together with 
other potentially APC-activating molecules, such as DNA, RNA, etc., lead to high 
proliferation rates in every samples, no matter, if xylose-induced or not (data not shown). 
Studies from Matsui et al (Matsui et al., 2007; Matsui and Nishikawa, 2012) indicated an 
impact of PGN sensing on the development of allergies. Therefore, we will perform 
additional DC-Th cell co-culture assays with subsequent analysis of the respective cytokine 
profiles with focus on IL-4 as major cytokine in Th2 responses. 
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Figure 21: Proliferation of CD4+ T cells after stimulation of APCs with culture supernatants 
Ovalbumin expression after induction with 0.5 % xylose of strain SA113Δspa pTX-sp-pp-ova led to a 
significant increase in proliferation of T cells, when compared to a non-ovalbumin producing strain and the 
same non-induced strain. Statistical analysis was done using a nonparametric one-way ANOVA model for 
repeated measurements with a Bonferroni adjustment. 
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Peptidoglycan (PGN) is ubiquitous in nearly all bacterial species. The PGN sacculus protects the cells against
their own internal turgor making PGN one of the most important targets for antibacterial treatment.
Within the last sixty years PGN composition has been intensively studied by various methods. The
breakthrough was the application of HPLC technology on the analysis of muropeptides. However,
preparation of pure PGN relied on a very time consuming method of about one week. We established a
purification protocol for both Gram-positive and Gram-negative bacteria which can be completely
performed in plastic reaction tubes yielding pure muropeptides within 24 hours. The muropeptides can be
analyzed by UPLC-MS, allowing their immediate determination. This new rapid method provides the
feasibility to screen PGN composition even in high throughput, making it a highly useful tool for basic
research as well as for the pharmaceutical industry.
T
he bacterial cell wall is mainly composed of peptidoglycan (PGN) with attached proteins and modifications
like wall teichoic acids (WTAs). PGN is a rigid structure of alternating N-Acetylglucosamine-N-
Acetylmuramic acid (GlcNAc-MurNAc) glycan chains cross-linked by peptides. The peptide moiety con-
sists of a stem peptide (L-Alanine –D-iGlutamate/iGlutamine – L-Lysin/meso-Diaminopimelic acid –D-Alanine
–D-Alanine). L-Lysin (L-Lys) ismainly a feature of Gram-positives, whilemeso-Diaminopimelic acid (mDAP) is
typical for Gram-negatives as well as for Bacillus subtilis. We will abbreviate the second amino acid of the stem
peptide by Glx which is either glutamine (Gln) or glutamate (Glu). Our model organism S. aureus harbors also a
five-glycine (Gly5) interpeptide bridge branching from the L-lysine (Lys), which constitutes indirect cross-links
between two adjacent stem peptides1. The resulting macromolecule forms a bag shaped sacculus covering the
whole bacterial cell. It is unique to bacteria ensuring their shape and protecting them against their own internal
turgor. Loss of its integrity results in cell lysis, making PGN one of the most important targets for antibacterial
treatment. Indeed, it is the target for well-known therapeutic drugs such as b-lactams or vancomycin, which all
inhibit the late steps of glycan chain polymerization and/or cross-linking, both occurring outside the cytoplasmic
membrane. With the emergence of new and highly multi-resistant bacterial strains, we are in an urgent need of
new anti-microbial drugs. Therefore, it is, amongst others, important to understand the complex interplay
between the PGN structure, (changes in) its chemical composition and also subsequent immune responses.
Since its first isolation in 1951 by Salton and Horne2 PGN composition has been intensively studied with
various methods. The original determination of the glycan and peptide composition was performed by paper
chromatography1. The breakthrough was by Glauner in 19883, who for the first time applied high pressure liquid
chromatography (HPLC) technology on the analysis of muropeptides. Muropeptides result from enzymatic
digestion of the glycan strands into disaccharides, with part of them still being cross-linked by peptides to various
extensions. Glauner extensively studied the effects of pH, buffer concentrations, and temperature on HPLC
separation of muropeptides of the Gram-negative bacterium E. coli. Later, a protocol for PGN isolation and
HPLC analysis of the Gram-positive Staphylococcus aureuswas established by deJonge et al.4. Basically, these two
protocols have been used ever since. However, both of them are very time consuming taking about a week to
obtain pure PGN. Both protocols rely onmultiple boiling steps with sodiumdodecylsulfate (SDS), which has to be
washed out by extensive ultracentrifugation steps for about an hour each. Last year a protocol for isolation of E.
coli PGN for ultra-performance liquid chromatography (UPLC) analysis was reported, that is substantially
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shorter5. However, it still relies on washing in an ultracentrifuge
thereby limiting the amounts of samples that can be prepared in
parallel.
PGN research has experienced a revival within the last decade.
Even PGN from bacteria like Chlamydiae, which had long been
thought to not contain a PGN sacculus, was now successfully isolated
and analyzed6. In addition, it had been shown, that growth condi-
tions7,8 as well as various antibiotics as b-lactams and daptomycin
affect PGN composition9–11. To test PGN composition of different
bacteria and under various conditions, a faster analysis method was
needed. One which allows to test several conditions in parallel and
which can also be applied to bacteria that are not easily grown in high
amounts.
We established a purification protocol which can be completely
performed in 2 ml reaction tubes, allowing the isolation of up to 48
samples in parallel or even in 96 well plates, yielding pure muropep-
tides in 24 hours. The muropeptides can be subsequently analyzed
byUPLC. This reduces the amount of sample needed and the analysis
time from about three hours (HPLC) to 70 min per sample. In
addition, the LC conditions were adapted to mass spectrometry
(MS) with suitable solvents so that the whole PGN can be directly
analyzed by UPLC-MS. This allows for muropeptide determina-
tion without first collecting and desalting LC peaks and results in
a complete PGN mapping. Taken together, the whole procedure is
reduced from about two weeks to 24 hours. Furthermore, this fast
isolation method also makes it much easier to obtain larger
amounts of PGN which can be used to collect special muropep-
tides that can then be tested for their ability to stimulate the
immune system12.
Results and Discussion
Peptidoglycan isolation. All steps are performed in 2 ml reaction
tubes with a U-shaped bottom. A detailed step-to-step protocol is
given in the online method. The method is based on the isolation of
PGN by boiling in 1 M NaCl. In the case of some Gram-positive
strains we experienced that NaCl treatment is not sufficient. A 0.25%
sodium dodecylsulfate (SDS) solution in 0.1 M Tris/HCl (pH 6.8)
was then used instead. The SDS has to be washed out again
thoroughly. A test for residual SDS is available and should be
performed13. The resulting cell walls are washed with water and
broken into smaller fragments by sonication. DNAse, RNAse, and
trypsin are used to digest residual nucleic acids as well as cell wall
bound proteins. The enzymes are inactivated by boiling and the cell
walls are washed again with water. Treatment with 1 N HCl releases
bound wall teichoic acids (WTA) or other glycophosphates. Higher
concentrations of HCl must be avoided, as they result in clumping of
the sample. In former protocols4, 48% HF was used to release WTA,
but comparison of PGN treated with HCl or with HF showed no
significant differences (see Fig. S1).Washing the pellet until the pH is
neutral results in pure PGN that can be digested by cell wall
hydrolases. In our case the PGN was digested with mutanolysin for
16 hours at 37uC shaking.
Peptidoglycan analysis by UPLC. Prior to UPLC analysis the
MurNAc residues of the muropeptides are reduced into NAc-
muraminitol by sodium borohydrate (NaBH4). Otherwise,
mutarotation of the non-reduced glycan end would result in
double peaks. Analysis is performed by UPLC (or HPLC) using
trifluoracetic acid (TFA) and a methanol gradient from 5 to 30%
(for Gram-positives) or from 0 to 30% (for Gram-negatives) in
70 min. TFA is an ion pairing agent that forms an ion bond with
the muropeptides resulting in a good separation of mixed analyts. As
TFA is volatile it can also be used for MS analysis. However, it
reduces the sensitivity of the mass spectrometer which might
require extra washing after use. After testing several different
columns, the reversed phase UPLC column CSH C18, 130A˚,
1.7 mm, 2.1 mm3 100 mm ofWaters was best suited for our needs.
Peptidoglycan mapping by UPLC-MS. The samples can also be
directly analyzed by UPLC-MS. We used a Synapt G2 mass
spectrometer coupled to a Waters Acquity H-class and operated in
positive ESI mode with a scan range from 50–2,000. The data was
analyzed byMassLynx. As an example for PGN isolation by this new
method, UPLC analysis andMS-mapping are presented in Fig. 1 and
Fig. 2. For Gram-positives we used Staphylococcus aureus (S. aureus)
SA11314 and for Gram-negatives Escherichia coli (E. coli) Nissle
191715.
Exemplary analysis of S. aureus SA113 by UPLC and UPLC-MS.
The methicillin sensitive S. aureus strain SA113 was grown over night
in BMmedium.We isolated its PGN and analyzed it by UPLC as well
as by UPLC-MS. This enabled us to directly determine the masses of
all muropeptide peaks we got by UPLC separation. The total ion
current (TIC) chromatogram obtained by UPLC-MS was almost
identical to the UV pattern of UPLC alone with two exceptions: 1)
Retention time of the peaks in the quaternary UPLC was about 1 min
longer than in the binary UPLC-MS system. Therefore, in tables 1
and S1 only the TIC retention times are given. 2) The signal of some
muropeptides, that turned out to be O-acetylated, were stronger in
the TIC than in the UV (e.g. peaks 9 in Fig. 1a and b).
The UV chromatogram of the UPLC as well as the TIC chromato-
gram of the MS show the expected pattern as it had been published
before for the methicillin resistant S. aureusCOL by de Jonge et al. in
19924,16. By coupling UPLC to MS we could directly determine the
masses and subsequently the potential structures of almost all peaks.
The obtained masses verified that the main peaks contained the
expected muropeptides starting with the monomeric peak 5
(Penta(Gln)Gly5) which is the basic structure of all muropeptides.
Peaks 11, 15, 16, 17 and 18 were composed of this basic structure
cross-linked by the Gly5 interpeptide bridge into dimers, trimers,
tetramers, pentamers, and hexamers, respectively (for general struc-
tures see Fig. 3). This proved that our substantially shortened puri-
fication method as well as the adaption of UPLC-MS is working
properly. Tab. 1 gives an overview on the muropeptides of the main
peaks that we detected in our analysis which had already been deter-
mined before4,17. The complete results of our PGN mapping of S.
aureus SA113 is given in Tab. S1. All structures were drawn by
ChemDrawUltra 13.0 (PerkinElmer), which automatically calcu-
lated the mass of the molecule and the proposed sum formula. The
latter is given. As can be judged by the peak forms in the UPLC
chromatogram, most peaks are composed of several muropeptides.
While all of them have the same basic structure (MurNac-GlcNac
with stem peptide and Gly5 interpeptide bridge), several modifica-
tions occur, which will be discussed in detail:
The lengths of the stem peptides are variable. Monomeric stem
peptides of S. aureus are mostly composed of the following five
amino acids (L-Ala – D-iGln – L-Lys– D-Ala – D-Ala) with the D-
iGln resulting from the amidation of the original D-iGlu18,19. These
structures are called ‘‘Pentas’’. Cross-linking of several muropeptides
by their interpeptide bridges forms multimeric muropeptides with
normally one Penta and several Tetras, as the last D-Ala is cleaved off
during the transpeptidation reaction. The resultingmuropeptides are
called ‘‘Penta-Tetran’’. However, several of the higher cross-linked
muropeptides had lost the last D-Ala on the Penta stem peptide
shortening it to a Tetra, forming ‘‘Tetran’’ muropeptides. No further
degradation into tripeptides was observed suggesting that S. aureus
does not possess an L,D-carboxypeptidase activity.
In S. aureus, the D-iGlu at position two of the stem peptide is
almost quantitatively amidated resulting in D-iGln18,19. However,
some muropeptides still harbor the original D-iGlu. While these
non-amidated forms have been published to have a shorter retention
time than their amidated counterparts18, in our system they had
www.nature.com/scientificreports
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longer retention times. This might be due to the different column
used for analysis.
The length and the composition of the interpeptide bridge varies. Gly
numbers that are not a multiple of 5 indicate that this verymuropeptide
was originally part of a biggermolecule but had been reorganized within
the PGN sacculus. For example we found monomeric muropeptides
with 6, 7, 8 or 9 Gly residues instead of 5, and dimeric muropeptides
with 6, 7, 8 or 9 Gly residues instead of 10. In Tab. 1 and Tab. S1 the
sum of all Gly residues of each muropeptide is given. In addition, two
muropeptides contained Ala in exchange for one Gly in the interpeptide
bridge. Muropeptides harboring various numbers of Gly residues or Ala
in their interpeptide bridge have been published before4.
There also occur changes in the saccharide moiety. Several mur-
opeptides had lost oneGlcNAc residue. In rare cases we also found an
additional GlcNAc residue, which resulted in a muropeptide with a
trisaccharide, but we did not observe the addition of an extra
MurNac. In table S1 the addition or loss of a GlcNAc residue is given
as 11 or 21 respectively.
Even though O-acetylation had been thought to be lost during
acidic treatment, we detected that most of the small peak groups,
as well as some of the peak shoulders, both of which had not been
analyzed so far, were composed of acetylated muropeptides. Even
treatment with HF did not result in a loss of the O-acetylated mur-
opeptides (see Fig. S1). As an example, peak 9 contained only the O-
Figure 1 | Muropeptide profile of S. aureus SA113 obtained by UPLC and UPLC/MS. (a) Muropeptide profile of S. aureus SA113 obtained by reversed
phase UPLC. (b) TIC of UPLC/MS analysis of S. aureus SA113 obtained by reversed-phase UPLC coupled to MS. Masses of indicated peaks are
shown in table 1 and table S1 including molecule composition and proposed sum formula.
www.nature.com/scientificreports
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acetylated monomer Penta-Gly5. If HF caused de-O-acetylation, this
peak should be missing in Fig. S1B, but it is not. The PGN of patho-
genic staphylococcal strains is highly O-acetylated on the 6th C-atom
of the MurNAc, which renders the bacterium resistant against lyso-
zyme20. Lysozyme is an enzyme produced by humans and animals as
a defense mechanism. It hydrolyzes PGN and therefore kills bacteria.
Figure 2 | Muropeptide profile of E. coli Nissle 1917 obtained by UPLC and UPLC/MS. (a)Muropeptide profile of E. coli Nissle 1917 obtained by
reversed phase UPLC. (b) TIC of UPLC/MS analysis of E. coliNissle 1917 obtained by reversed-phase UPLC coupled toMS.Masses of indicated peaks are
shown in table 2 and table S2 including molecule composition and proposed sum formula.
Table 1 | Muropeptides of S. aureus SA113 analyzed by UPLC-MS
Peak Reten-tion time in TIC [min]
M1H1
Proposed sum formula Lengths of the stem peptides
Inter-peptide bridges
Prev. pub.Measured Gly Ala
2 8.56 1239.5792 C48H83N14O241 Tetra 6 4
4 10.17 1025.5032 C41H73N10O201 Penta 1 4
5b 11.08 1253.5861 C49H85N14O241 Penta 5 4
8 14.20 1267.6096 C50H87N14O241 Penta 4 1 4
11b 21.93 2417.1181 C95H162N27O461 Penta-Tetra 10 4
12b 23.12 2328.0745 C92H155N26O441 Tetra2 (cyclic) 10 17
15b 27.45 3580.6630 C141H239N40O681 Penta-Tetra2 15 4
16a 30.80 4744.1962 C187H316N53O901 Penta-Tetra3 20 4
17a 33.01 5907.7014 C233H393N66O1121 Penta-Tetra4 25
18 34.90 7071.2313 C279H470N79O1341 Penta-Tetra5 30
Each muropeptide contains one to six stem-peptides, each consisting of L-Ala – D-Gln – L-Lys – D-Ala (– D-Ala). The amount of Gly molecules building the interpeptide bridges is given as the sum of all Gly
residues present in each muropeptide. In rare cases one Gly is replaced by an Ala. The last column refers to the original reference of the respective muropeptide.
www.nature.com/scientificreports
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Even though we cannot exclude that part of the O-acetylation is lost
during isolation, a change of the respective peaks would be an indica-
tion for changes in the O-acetylation grade and could be useful to
screen for possible mutants or for drugs affecting O-acetylation.
A very small amount of MurNac residues seemed not to be com-
pletely reduced to NAc-muraminitol. This also resulted in longer
retention times compared to the reduced counterparts.
Exemplary analysis of E. coliNissle 1917 by UPLC and UPLC-MS.
As an example for Gram-negative bacteria we grew E. coliNissle 1917
overnight in LBmedium and isolated its PGN. The PGNwas digested
by mutanolysin and analyzed by UPLC and UPLC-MS (Fig. 2).
Again, the UV pattern was very similar to the TIC chromatogram
and we could determine the masses of most muropeptide peaks. The
masses we found resulted in proposed muropeptide structures that
are in accordance with the ones previously published by Glauner3
(Tab. 2). The complete analysis is given in Tab. S2.
We found the expectedmonomericmuropeptides with the Tri and
the Tetra stem-peptide (peak 1 and 4, respectively), the dimeric
muropeptides Tetra-Tri and Tetra-Tetra (peaks 7 and 8, respect-
ively) as well as in small amounts the trimeric muropeptide Tetra-
Tetra-Tetra (peak 10). (For a schematic drawing of the Gram-
negative muropeptides see Fig. 3b). Interestingly, for the Tetra, the
Tetra-Tri and the Tetra-Tetra, we always got two peaks in the TIC
chromatogram but only one in the UV chromatogram.We fragmen-
ted the respective peaks and they seem to be stereo-isomers as in all
Figure 3 | Schematic structure of muropeptides of S. aureus and E. coli. The basic structure consists of the disaccharide (GlcNAc-MurNAc) with an
adjacent stem peptide (L-Ala – D-iGlx – L-Lys – D-Ala – D-Ala) with Glx being either Gln or Glu. Our model organism S. aureus, harbors also
a five-glycine interpeptide bridge branching from the L-Lys, which constitutes indirect cross-links between two adjacent stem peptides, as it is depicted in
the multimeric muropeptide. The C at position 6 of the MurNAc can be O-acetylated.
Table 2 | Muropeptides of E. coli Nissle 1917 analyzed by UPLC-MS
Peak Reten-tion time in TIC [min]
M1H1
Proposed sum formula Length of the stem peptides Prev. pub.Measured
1 9.27 871.3793 C34H59N6O201 Tri 3
2 9.95 928.3986 C36H62N7O211 Tetra-Gly(4) 3
3 11.69 699.2936 C27H47N4O171 Di 3
999.4775 C39H67N8O221 Penta-Gly(5) 3
4a 12.81 942.4180 C37H64N7O211 Tetra
4b 13.50 942.4177 C37H64N7O211 Tetra 3
5a 22.40 1851.8278 C73H123N14O411 Tetra-Tetra-Gly(4)
5b 23.10 1851.7966 C73H123N14O411 Tetra-Tetra-Gly(4) 3
6 23.60 1922.8710 C76H128N15O421 Tetra-Penta-Gly(5) 3
1794.7766 C71H120N13O401 Tetra-Tri 3
7 24.70 1794.7758 C71H120N13O401 Tetra-Tri 3
8a 25.59 1865.8140 C74H125N14O411 Tetra-Tetra
8b 26.18 1865.8140 C74H125N14O411 Tetra-Tetra 3
9 29.75 2846.2697 C113H189N22O621 Penta-Gly(5)-Tetra-Tetra
10 32.40 2789.2146 C111H186N21O611 Tetra-Tetra-Tetra 3
11 35.30 1845.7744 C74H121N14O401 anhydro Tetra-Tetra 3
Eachmuropeptide contains one to three stem-peptides, each consisting of L-Ala –D-Glu –mDAP –D-Ala. In some cases the D-Ala on position four is replaced by aGly. Somemuropeptides contain Penta stem-
peptides with Gly on position five. The last column refers to the original reference of the respective muropeptide.
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three cases closely related fragmentation spectra with different rela-
tive fragment peak intensities were obtained. Fig. S2 gives the exem-
plary fragmentation of peaks 8a and 8b, both being the Tetra-Tetra
muropeptide. We did not get any hints for mDap-mDap-crosslink-
ing, as it had been seen in strain E. coli W73.
The monomeric peak 3 in the TIC chromatogram is not in cor-
relation with any peak of the UV chromatogram. Vice versa, the UV
chromatogram has two unlabeled peaks, for which we cannot assign
a muropeptide. Peak 3 of the TIC chromatogram contains 4 muro-
peptides (Tab. S2) with two of them being already known from the
Glauner analysis3, the Di and the Penta-Gly(5) monomer. While
these two peaks in the Glauner analysis have a higher retention time
than the Tetra, they have a shorter retention timewhen analyzedwith
our conditions. The same is seen for Tetra-Penta-Gly(5) (peak 6)
which in our system elutes before the Tetra-Tri and not after it.
With these few exceptions the elution profile of the E. coli mur-
opeptides under our conditions is the same as already known. We
also found one anhydro Tetra-Tetra muropeptide (peak 11), but we
did not find any structures still containing lysine and arginine, which
would be remnants from Braun’s Lipoprotein21. Instead we found
masses corresponding to muropeptides which had lost the GlcNAc
moiety (Tab. S2). These are probably features of the strain we used.
As expected, in all muropeptides with a Penta stem-peptide, the
amino acid in position five is a Gly, as the last D-Ala is cleaved off
by the D,D-carboxypeptidase penicillin-binding protein (PBP) 522.
We did obtain masses for the peaks between minutes 14 and 21, but
they did not fit any muropeptide structures and are therefore not
given.
Conclusion
We have presented here a very quick method for PGN isolation with
additional analysis on UPLC-MS all within 24 hours. This method is
suitable for high throughput screening of various bacterial strains or
growth conditions, as it is performed in either 2 ml plastic reaction
tubes or even in microtiter plates. With this new procedure we
mapped the whole PGN of S. aureus SA113 up to the hexameric
cross-linked muropeptide. In addition to the already known muro-
peptide structures of the prevalent peaks we have also presented
masses and structures for the so far unidentified smaller peak groups
in between. As an example for Gram-negatives we analyzed the PGN
of E. coli Nissle 1917 and corroborated former publications.
Methods
The protocols will also be provided at www.nature.com/protocolexchange.
Bacterial strains. S. aureus SA11314 and E. coli Nissle 191715.
Cell growth. The cells were grown in their respective medium to the needed OD.
Basicmedium (BM) for S. aureus consisted of Soy Peptone (10 g; Plato), Yeast Extract
(5 g; Deutsche Hefewerke), NaCl (5 g; Carl-Roth), Glucose (1 g; Carl Roth) and
K2HPO4 (1 g; Applichem). Deionized water was added to a final volume of 1 liter and
pH was adjust to 7.2. LB medium for E. coli consisted of Peptone (10 g; Plato), Yeast
Extract (5 g; Deutsche Hefewerke) and NaCl (5 g; Carl Roth). Deionized water was
added to a final volume of 1 liter and pH was adjust to 7.2.
Reagents. Unless otherwise stated, all reagents were bought from Sigma-Aldrich.
Midipreparation for UPLC/MS or HPLC/MS analysis. This protocol results in
sample amounts suitable for several analyses. From 2 ml of culture of OD578 < 10
about 300 ml purified PGN are gained. Spin down 2 ml of an overnight culture in a
2 ml microcentrifuge tube (Eppendorf) for 5 min at 10,000 rpm. Alternatively: Spin
down 23 2 ml of a culture with a lower OD. Resuspend the pellet in 1 ml solution A
(1 M sodium chloride) and boil the suspension for 20 minutes at 100uC in a heating
block. [D CRITICAL STEP 1: Sometimes, NaCl treatment is not sufficient for
peptidoglycan isolation from the cells. Use 0.25% SDS solution in 0.1 M Tris/HCl
(pH 6.8) instead. SDS has to be washed out thoroughly after boiling. Make sure the
samples are boiling at 100uC. Bad isolation results are mostly caused by too low heat.]
Spin down the suspension (5 min at 10,000 rpm), wash it at least twice with 1.5 ml
ddH2O and resuspend the pellet in 1 ml ddH2O. Put the sample to a sonifier
waterbath for 30 minutes. Add 500 ml of solution B (15 mg/ml DNase and 60 mg/ml
RNase in 0.1 M TRIS/HCl, pH 6.8) and incubate for 60 minutes at 37uC in a shaker.
Add 500 ml of solution C (50 mg/ml trypsin in ddH2O) and incubate for additional 60
minutes at the same conditions. To inactivate the enzymes boil the suspension for 3
minutes at 100uC in a heating block, then spin the sample down (5 min at
10,000 rpm) andwash it once with 1 ml ddH2O.To releaseWTA resuspend the pellet
in 500 ml of 1 MHCl (ready-to-use solution fromApplichem) and incubate for 4 h at
37uC in a shaker. Spin down the suspension (5 min at 10,000 rpm) and wash with
ddH2O until the pH is 5–6. Afterwards, resuspend the pellet in 100–250 ml digestion
buffer (12.5 mM sodium dihydrogen-phosphate, pH 5.5) to an OD578 of 3.0 and add
1/10 volume of mutanolysin solution (5.000 U/ml of mutanolysin in ddH2O). [D
CRITICAL STEP 2: If OD578 is too high the sample is too concentrated. Therefore, the
digestion with mutanolysin might be disturbed. Measurement of OD is tricky,
because peptidoglycan sinks to the bottom. Mix the suspension carefully with a
pipette and measure OD rapidly.] Then incubate the sample for 16 h at 37uC
(150 rpm shaking). Inactivate mutanolysin by boiling (100uC) for 3 min. Spin the
sample down (5 min at 10,000 rpm) and use the supernatant. Before applying the
sample to the UPLC system, MurNAc has to be reduced to NAc-muraminitol.
Therefore, add 50 ml of reduction solution (10 mg/ml sodium borohydrate in 0.5 M
borax in ddH2O at pH 9.0; both reagents were purchased from Merck) and incubate
the sample for 20 minutes at room temperature. Stop the reaction with 10 ml
phosphoric acid (98%). The resulting pH must be between 2 and 3. Then analyze the
sample by UPLC/MS or HPLC/MS.
Minipreparation in 96 well plate for UPLC/MS analysis. This protocol gives just
enough material for one sample for UPLC/MS analysis. For different growth
parameters, use a divisible 96 well plate. Use a multichannel pipette for all
resuspension steps. Always cover the samples properly with a foil (Greiner) or lid to
avoid evaporation or mixing of samples!
Always use a 96 well-plate with U-shaped bottom (Greiner). Spin down 200 ml of
the culture for 10 min at 4,700 rpm in a plate centrifuge. Resuspend each pellet in
200 ml solution A (1 M sodium chloride) and boil the suspension for 30 minutes at
100uC in a heating block. [D CRITICAL STEP 1: Sometimes, NaCl treatment is not
sufficient for peptidoglycan isolation from the cells. Use 0.25% SDS solution in 0.1 M
Tris/HCl (pH 6.8) instead. SDS has to be washed out thoroughly after boiling.] The
plate must be covered with foil. Make sure the samples are boiling at 100uC. Bad
isolation results aremostly caused by too low heat. Spin down the suspension (10 min
at 4,700 rpm with foil coverage or lid) and wash at least twice with 200 ml ddH2O.
Afterwards, resuspend each pellet in 150 ml ddH2O. Close the wells carefully with a
foil coverage (NOT lid), so that no water can ingress to the sample. Place the plate to a
sonifier waterbath for 30 minutes (plate floats). Spin down the suspension (10 min at
4,700 rpm) and resuspend each pellet in 100 ml of solution B (15 mg/ml DNase and
60 mg/ml RNase in 0.1 M TRIS/HCl, pH 6.8). Properly close plate with foil coverage
and incubate for 60 minutes at 37uC in a shaker at 150 rpm. It is better to place
samples at the edge of the shaker than in themiddle. Add 100 ml of solution C (50 mg/
ml trypsin in ddH2O), properly close plate with foil coverage and incubate for another
60 minutes at 37uC in a shaker at 150 rpm. To inactivate the enzymes boil the
suspension for 5 minutes at 100uC. Spin down the suspension (10 min at 4,700 rpm)
and wash each pellet once with 200 ml ddH2O. To releaseWTA resuspend each pellet
in 200 ml of 1 MHCl (ready-to-use solution fromApplichem) and incubate for 4 h at
37uC in a shaker (150 rpm, with foil coverage). Spin down the suspension (10 min at
4,700 rpm) andwash pellets with ddH2Ountil the pH is 5–6. Resuspend each pellet in
50 ml digestion buffer (12.5 mM sodium dihydrogen-phosphate, pH 5.5) and add
5 ml mutanolysin solution (5.000 U/ml of mutanolysin in ddH2O). Incubate the well
plate for 16 h at 37uC (at 150 rpm, with foil coverage). Boil the samples on the heating
block (100uC) for 5 minutes to inactivate mutanolysin. Afterwards spin the plate
down (10 min at 4,700 rpm) and use the supernatant. Before applying the samples to
the UPLC system, MurNAc has to be reduced to NAc-muraminitol. Add 10 ml of the
reduction solution (10 mg/ml sodium borohydrate in 0.5 M borax in ddH2O at pH
9.0; both reagents were purchased from Merck) to each sample and incubate for
20 min at room temperature. [DCRITICAL STEP 2: The reduction solution contains
a lot of bubbles. Transfer of the exact volume of 10 ml reduction solution is not
possible. Set your pipette to a volume of 100 ml and add 1 drop to each sample. This
accords to the needed volume.] Stop the reaction with 5 ml phosphoric acid (50%).
The pHmust be between 2 and 3 (add phosphoric acid very slow and carefully!). Then
analyze the samples by UPLC or UPLC/MS.
UPLC/MS ANALYSIS. An Acquity UPLC was coupled to a SynaptG2 mass
spectrometer (both Waters). We used a C18 CSH 130A˚, 1.7 mm, 2.1 mm3 100 mm
columnwith the respective guard column (C18CSH130A˚, 1.7 mm, 2.1 mm3 5 mm)
available at Waters. As MS standard L-Enk was used.
The column temperature was 52uC and the injection volume was 10 ml with no
loop overfill. Muropeptides were detected at 210 nm (DAD) or by MS. The MS was
set to positive ESI mode with a scan range from 50–2,000. The capillary voltage was
3 kV. The sampling cone was set to 30 and the extraction cone to 3.0. Source tem-
perature was set to 120uC and desolvation temperature to 450uC. The flow of the cone
gas was 10 l/h and of the desolvation gas 800 l/h.
For muropeptide separation by UPLC/MS we used solvent A (0.1% TFA in 5%
methanol; for Gram-negatives omit methanol) and solvent B (0.1% TFA in 30%
methanol). TFA (trifluoroacetic acid) was bought from Carl Roth, methanol (UV
grade) from Sigma-Aldrich. We applied a flow rate of 0.176 ml/min starting with
100% solvent A for 1 min. Afterwards, a linear gradient was run in 59 min to 100%
solvent B. The post run was 5 min with 100% solvent B and additional 10 min with
100% solvent A for re-equilibration. [D CRITICAL STEP: A long and intensive
equilibration of the column and an exact column temperature is very important.
www.nature.com/scientificreports
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Wash the column 30 min with methanol, 30 min with ddH2O water, 30 min with
solvent B, and 30 minwith solvent A to a steady baseline. Degassed solvents should be
self-evident.]
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Table S1: Muropeptides of S. aureus SA113 analyzed by UPLC-MS 
This table gives a summary of all muropeptides of S. aureus SA113 that could be detected 
by UPLC-MS. All structures were drawn by ChemDrawUltra (PerkinElmer) which 
automatically calculates the mass of the molecule and the sum formula. The latter is given. 
Each muropeptide contains one to six stem-peptides, each consisting of L-Ala – D-Glx – L-
Lys – D-Ala (– D-Ala). In general, Glx is Gln. Non-amidated Glu is indicated separately. The 
length of each of the stem peptides is stated. The amount of Gly residues building the 
interpeptide bridges is given as the sum of all Gly residues present in each muropeptide. In 
rare cases one Gly is replaced by one Ala. Changes on the saccharide moiety (loss or 
addition of GlcNAc; O-Acetylation; rare non-reduced MurNAc) are shown. The muropeptides 
of the main peaks, which are also given in Tab. 1, are highlighted in bold. In Tab. 1 also the 
original references for these peaks are given. n.d. … not determined 
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Table S1: Muropeptides of S. aureus SA113 analyzed by UPLC-MS 
 0 
Peak 
Retention 
time in TIC 
[min] 
M+H+ Proposed  
sum formula 
Lengths of the 
stem peptides 
Non-
amidated 
Glu 
Interpeptide 
bridges 
Changes in the  
saccharide moiety 
Measured Gly Ala GlcNAc O-Acetyl non-red. 
1    7.61   979.4799 n.d. 
       
2 
   8.56 
shoulder 
1036.4937 C40H70N13O19+ Tetra 
 
6 
 
-1 
  
1093.5164 C42H73N14O20+ Tetra 
 
7 
 
-1 
  
1150.5417 C44H76N15O21+ Tetra 
 
8 
 
-1 
  
1207.5699 C46H79N16O22+ Tetra 
 
9 
 
-1 
  
   8.56 
1239.5699 C48H83N14O24+ Tetra 
 
6 
    
1296.5939 C50H86N15O25+ Tetra 
 
7 
    
1353.6135 C52H89N16O26+ Tetra 
 
8 
    
1410.6370 C54H92N17O27+ Tetra 
 
9 
    
3    9.24 954.4640 C38H68N9O19+ Tetra 1 1 
    
4 10.17 
1025.5032 C41H73N10O20+ Penta 
 
1 
    
1182.5502 C46H80N13O23+ Tetra 
 
5 
    
5a 10.86 
879.4431 C35H63N10O16+ Penta 
 
2 
 
-1 
  
936.4638 C37H66N11O17+ Penta 
 
3 
 
-1 
  
1082.5231 C43H76N11O21+ Penta 
 
2 
    
1139.5428 C45H79N12O22+ Penta 
 
3 
    
5b 11.08 
1050.5082 C41H72N13O19+ Penta 
 
5 
 
-1 
  
1253.5861 C49H85N14O24+ Penta 
 
5 
    
6 12.52 1224.5674 C48H82N13O24+ Tetra 
 
5 
  
1 
 
7 13.02 1254.5664 C49H84N13O25+ Penta 1 5 
   
1 
8 14.20 1267.6096 C50H87N14O24+ Penta 
 
4 1 
   
9 16.68 1295.5968 C51H87N14O25+ Penta 
 
5 
  
1 
 
4 
 
Peak 
Retention 
time in TIC 
[min] 
M+H+ Proposed 
sum formula 
Lengths of the 
stem peptides 
Non-
amidated 
Glu 
Interpeptide 
bridges 
Changes in the  
saccharide moiety 
Measured Gly Ala GlcNAc O-Acetyl non-red. 
10 
19.00  
to 
19.70 
1296.5902 C51H86N13O26+ Penta 1 5 
  
1 
 
2143.0192 C85H144N23O41+ Penta-Tetra 2 8 
 
-1 1 
 
2574.1760 C101H169N28O50+ Tetra2 1 13 
  
1 
 
2199.9962 C87H147N24O42+ Penta-Tetra 1 9 
 
-1 1 
 
2257.0518 C89H150N25O43+ Penta-Tetra 1 10 
 
-1 1 
 
2289.0616 C91H154N23O45+ Penta-Tetra 
 
7 
  
1 
 
2346.0781 C93H157N24O46+ Penta-Tetra 
 
8 
  
1 
 
2403.0937 C95H160N25O47+ Penta-Tetra 
 
9 
  
1 
 
2460.1237 C97H163N26O48+ Penta-Tetra 
 
10 
  
1 
 
11a 21.52 
2189.0486 C87H150N23O42+ Penta-Tetra 
 
6 
    
2346.0766 C93H157N24O46+ Penta-Tetra 1 8 
  
1 
 
11b 21.93 2417.1181 C95H162N27O46+ Penta-Tetra 
 
10 
    
12a 22.52 2124.9932 C84H142N25O39+ Tetra2 (cyclic) 
 
10 
 
-1 
  
12b 23.12 2328.0745 C92H155N26O44+ Tetra2 (cyclic) 
 
10 
    
13a 23.47 2418.1006 C95H161N26O47+ Penta-Tetra 1 10 
    
13b 24.34 2431.1341 C96H164N27O46+ Penta-Tetra 
 
9 1 
   
14a 24.81 
2329.0461 C92H154N25O45+ Tetra2 (cyclic) 1 10 
    
2415.1060 C95H160N27O46+ Penta-Tetra 
 
10 
   
1 
14b 25.04 
2388.1040 C94H159N26O46+ Tetra-Tetra  10   1  
2415.1072 C95H160N27O46+ Penta-Tetra  10    1 
3509.6299 C139H234N37O68+ Penta-Tetra2 
 
13 
  
1 
 
1 
5 
 
 2 
Peak 
Retention 
time in TIC 
[min] 
M+H+ Proposed  
sum formula 
Lengths of the 
stem peptides 
Non-
amidated 
Glu 
Interpeptide 
bridges 
Changes in the  
saccharide moiety 
Measured  
 
 Gly Ala GlcNAc O-Acetyl non-red. 
14c 25.47 
2185.0298 C87H146N23O42+ Penta-Tetra 
 
6 
   
2 
2388.1040 C94H159N26O46+ Tetra-Tetra 
 
10 
  
1 
 
14d 25.67 2256.0534 C89H151N26O42+ Penta-Tetra 
 
10 
 
-1 1 
 
14e 25.85 
3566.7134 C140H237N40O68+ Penta-Tetra2 
 
16 
  
1 
 
2459.1380 C97H164N27O47+ Penta-Tetra 
 
10 
  
1 
 
14f 26.74 3567.6179 C141H236N37O70+ Penta-Tetra2 2 14 
  
1 
 
15a 27.23 
2460.1220 C97H163N26O48+ Penta-Tetra 1 10 
  
1 
 
3281.5076 C130H222N35O63+ Tetra3 
 
11 
    
3377.5886 C133H226N39O63+ Penta-Tetra2 
 
15 
 
-1 
  
3509.6465 C138H234N39O67+ Tetra3 
 
15 
    
15b 27.45 
3352.5787 C133H227N36O64+ Penta- Tetra2 
 
11 
    
3377.5886 C133H226N39O63+ Penta- Tetra2 
 
15 
 
-1 
  
3580.6630 C141H239N40O68+ Penta- Tetra2  15     
15c 28.50 3581.6525 C141H238N39O69+ Penta-Tetra2 1 15 
    
15d 29.35 
3507.6278 C138H232N39O67+ Tetra3 
 
15 
   
1 
3547.8803 C140H232N39O68+ Tetra3 
 
15 
  
1 2 
3578.6621 C141H237N40O68+ Penta-Tetra2 
 
15 
   
1 
4730.1515 C187H314N51O91+ Penta-Tetra2 1 15 
  
1 
 
15e 30.19 
3394.5530 C134H228N37O65+ Tetra3 1 13 
   
1 
3419.6141 C135H228N39O64+ Penta-Tetra2 
 
15 
 
-1 1 
 
3551.6252 C140H236N39O68+ Tetra3 
 
15 
  
1 
 
3622.6978 C143H241N40O69+ Penta-Tetra2  15   1  
3 
6 
 
 4 
Peak 
Retention 
time in TIC 
[min] 
M+H+ Proposed  
sum formula 
Lengths of the 
stem peptides 
Non-
amidated 
Glu 
Interpeptide 
bridges 
Changes in the  
saccharide moiety 
Measured Gly Ala GlcNAc O-Acetyl non-red. 
15e 30.19 3622.6978 C143H241N40O69+ Penta-Tetra2 
 
15 
  
1 
 
15f 30.40 3622.6910 C143H241N40O69+ Penta-Tetra2 
 
15 
  
1 
 
16a 30.80 
4541.1010 C179H303N52O85+ Penta-Tetra3 
 
20 
 
-1 
  
4673.1534 C184H311N52O89+ Tetra4 
 
20 
    
4744.1962 C187H316N53O90+ Penta-Tetra3 
 
20 
    
16b 31.60 
4742.0843 C187H314N53O90+ Penta-Tetra3  20 
   
1 
4745.1578 C187H315N52O91+ Penta-Tetra3 1 20     
16c 32.44 
4742.2070 C187H314N53O90+ Penta-Tetra3 
 
20 
   
1 
3620.6402 C143H239N40O69+ Penta-Tetra2 
 
20 
  
1 1 
4539.0782 C179H301N52O85+ Penta-Tetra3 
 
20 
 
-1 
  
4671.1277 C184H309N52O89+ Tetra4 
 
20 
    
17a 33.01 
4786.2042 C189H318N53O91+ Penta-Tetra3 
 
20 
  
1 
 
3664.6502 C145H243N40O70+ Penta-Tetra2 
 
15 
  
2 
 
5836.6706 C230H388N65O111+ Tetra5 
 
25 
    
5907.7014 C233H393N66O112+ Penta-Tetra4 
 
25 
    
17b 33.77 
5907.6914 C233H393N66O112+ Penta-Tetra4 
 
25 
    
4787.1722 C189H318N53O91+ Penta-Tetra3 1 20 
  
1 
 
18 34.90 
4784.1642 C189H316N53O91+ Penta-Tetra3 
 
20 
  
1 1 
4828.2174 C191H320N53O92+ Penta-Tetra3 
 
20 
  
2 
 
5746.6426 C227H382N65O108+ Penta-Tetra4  25  -1 1  
5878.6954 C232H390N65O112+ Tetra5  25   1  
5949.7002 C235H395N66O113+ Penta-Tetra4  25   1  
7071.2313 C279H470N79O134+ Penta-Tetra5  30     
7 
 
Table S2: Muropeptides of E. coli Nissle 1917 analyzed by UPLC-MS 5 
This table summarizes the muropeptides of E. coli Nissle 1917 that could be detected by 6 
UPLC-MS. The sum formula to each mass is given. Each muropeptide contains one to three 7 
stem-peptides, each consisting of L-Ala – D-Glu – mDAP – D-Ala (– Gly). The length of each 8 
of the stem peptides is stated. In some cases Penta stem-peptides with Gly on position 5 are 9 
present. Loss of GlcNAc or acetyl is shown as -GlcNAc and -Acetyl. The muropeptides of the 10 
main peaks, which are also given in Tab. 2, are highlighted in bold.  11 
 12 
Peak 
Reten-
tion 
time in 
TIC 
[min] 
M+H+ Proposed sum 
formular 
Length of the stem 
peptides 
Measured 
1 9.27 871.3793 C34H59N6O20+ Tri 
668.2999 C26H46N5O15+ Tri (-GlcNac) 
2 9.95 
928.3986 C36H62N7O21+ Tetra-Gly(4) 
725.3201  C28H49N6O16+ Tetra-Gly(4) (-GlcNac) 
999.4708 C39H67N8O22+ Penta-Gly(5) 
3 11.69 
699.2936 C27H47N4O17+ Di 
999.4775 C39H67N8O22+ Penta-Gly(5) 
900.4092 C35H62N7O20+ Tetra (-Acetyl) 
796.3969 C31H54N7O17+ Penta-Gly(5) (-GlcNac) 
4a 12.81 942.4180 C37H64N7O21+ Tetra 
4b 13.50 942.4177 C37H64N7O21+ Tetra 
739.3378 C29H51N6O16+ Tetra (-GlcNac) 
5a 22.40 1851.8278 C73H123N14O41+ Tetra-Tetra-Gly(4) 
5b 23.10 1851.7966 C73H123N14O41+ Tetra-Tetra-Gly(4) 
6 23.60 1922.8710 C76H128N15O42+ Tetra-Penta-Gly(5) 
1794.7766 C71H120N13O40+ Tetra-Tri 
7 24.70 1794.7758 C71H120N13O40+ Tetra-Tri 
8a 25.59 1865.8140 C74H125N14O41+ Tetra-Tetra 
8b 26.18 1865.8140 C74H125N14O41+ Tetra-Tetra 
9 29.75 2846.2697 C113H189N22O62+ Penta (Gly5)-Tetra-Tetra 
10 32.40 2789.2146 C111H186N21O61+ Tetra-Tetra-Tetra 
11 35.30 1845.7744 C74H121N14O40+ anhydro Tetra-Tetra 
 13 
14 
8 
 
 15 
 16 
Fig. S1: Comparison of isolated peptidoglycan treated with HCl and HF 17 
We compared the muropeptide pattern of peptidoglycan of S. aureus SA113 treated with 18 
either HCl (a) or HF (b). The HF treated muropeptide pattern shows no differences compared 19 
to the HCl treated one. 20 
21 
9 
 
 22 
 23 
Fig. S2: Fragmentation of E. coli Nissle 1917 Peaks 8a and 8b 24 
The peaks 8a and 8b were fragmented (MSE all ion fragmentation, bottom panel). The 25 
resulting fragment patterns are closely related, but the relative fragment peak intensities 26 
vary. This, in combination with the close but different chromatographic retention times, is 27 
typically caused by two stereoisomers. This is also seen in the top panel, where the search 28 
for the respective mass resulted in two peaks. 29 
NOD2 Stimulation by Staphylococcus aureus-Derived Peptidoglycan Is
Boosted by Toll-Like Receptor 2 Costimulation with Lipoproteins in
Dendritic Cells
Holger Schäffler,a Dogan Doruk Demircioglu,b Daniel Kühner,b Sarah Menz,c,d Annika Bender,c,d Ingo B. Autenrieth,c,d
Peggy Bodammer,a Georg Lamprecht,a Friedrich Götz,b Julia-Stefanie Frickc,d
Division of Gastroenterology, Department of Medicine II, University of Rostock, Rostock, Germanya; Microbial Genetics, University of Tübingen, Tübingen, Germanyb;
Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germanyc; Deutsches Zentrum für Infektionsforschung (DZIF), Partner Side Tübingen,
Tübingen, Germanyd
Mutations in the nucleotide-binding oligomerization domain-containing protein 2 (NOD2) play an important role in the patho-
genesis of Crohn’s disease. NOD2 is an intracellular pattern recognition receptor (PRR) that senses bacterial peptidoglycan
(PGN) structures, e.g., muramyl dipeptide (MDP). Here we focused on the effect of more-cross-linked, polymeric PGN frag-
ments (PGNpol) in the activation of the innate immune system. In this study, the effect of combined NOD2 and Toll-like recep-
tor 2 (TLR2) stimulation was examined compared to single stimulation of the NOD2 receptor alone. PGNpol species derived
from a lipoprotein-containing Staphylococcus aureus strain (SA113) and a lipoprotein-deficient strain (SA113 lgt) were iso-
lated. While PGNpol constitutes a combined NOD2 and TLR2 ligand, lipoprotein-deficient PGNpollgt leads to activation of the
immune system only via the NOD2 receptor. Murine bone marrow-derived dendritic cells (BMDCs), J774 cells, andMonoMac 6
(MM6) cells were stimulated with these ligands. Cytokines (interleukin-6 [IL-6], IL-12p40, and tumor necrosis factor alpha
[TNF-]) as well as DC activation andmaturation parameters were measured. Stimulation with PGNpollgt did not lead to en-
hanced cytokine secretion or DC activation andmaturation. However, stimulation with PGNpol led to strong cytokine secretion
and subsequent DCmaturation. These results were confirmed inMM6 and J774 cells. We showed that the NOD2-mediated acti-
vation of DCs with PGNpol was dependent on TLR2 costimulation. Therefore, signaling via both receptors leads to a more po-
tent activation of the immune system than that with stimulation via each receptor alone.
Crohn’s disease is a systemic inflammatory disease, and to-gether with ulcerative colitis, it forms the complex of inflam-
matory bowel diseases (IBD). Mutations within the NOD2 gene,
encoding nucleotide-binding oligomerization domain-contain-
ing protein 2 (NOD2), have been identified as risk factors for the
development of Crohn’s disease (1–3). NOD2 is an intracellular
pattern recognition receptor that senses peptidoglycan (PGN)
fragments, such as muramyl dipeptide (MDP), derived from
Gram-positive bacteria, to activate a cascade of reactions which
consecutively lead to the activation of the transcription factor
NF-B (4).
Dendritic cells (DCs) are important professional antigen-pre-
senting cells (APCs) in the intestine (5, 6) and are crucial for T cell
activation and polarization (7, 8). Depending on the antigen, DCs
can promote either inflammation or tolerance (9). DCs are
thought to contribute to the pathogenesis of Crohn’s disease (10,
11) by inducing T cell activation via antigen presentation. As an
example, colonic CD11cDCs isolated from inflamed parts of the
gut from IBDpatients showed an increased expression of Toll-like
receptor 2 (TLR2), TLR4, and the costimulatory molecule CD40
compared to DCs from noninflamed areas or DCs from healthy
controls (12). Also, the ability of DCs to induce tolerogenic regu-
latory T cells might be lost in Crohn’s disease patients (13).
PGN fragments with a low degree of cross-linking, such as
PGN monomers, have been shown to be natural ligands for the
NOD2 receptor (14). However, the role of more-cross-linked
PGN fragments, so called polymeric PGN (PGNpol), and their
effect in stimulating immune cells are still unclear, as even highly
purified PGNpol might be contaminated with potent immune-
stimulating lipoproteins (15). UsingBacillus anthracis peptidogly-
can, it has been shown that polymeric PGN is a more potent acti-
vator of innate immune cells thanMDP ormonomeric PGN (16).
The importance of PGN in inflammation was recently demon-
strated in mice infected with wild-type (WT) Staphylococcus au-
reus and corresponding O-acetyltransferase A (OatA) mutants. In
S. aureus, PGN is modified by an O-acetyltransferase at the C-6
OH position of N-acetylmuramic acid (17). This modification,
which occurs only in pathogenic staphylococcal strains (18), con-
fers complete resistance of PGN to lysozyme, while mutations of
the oatA gene result in a PGN that is sensitive to lysozyme (17, 19).
In comparing PGNpol from WT S. aureus with PGN from the
oatA-deficient mutant (S. aureus oatA), it turned out that WT
PGNpol strongly suppressed interleukin-1 (IL-1) secretion
and inflammasome activation, while the PGNpol of the S. aureus
oatA strain strongly increased IL-1 secretion and inflam-
masome activation (20). In the absence of oatA, PGN is degraded
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by lysozyme, resulting in a number of PGN breakdown products
which boost inflammation. Thus,modification of PGNbyO-acet-
ylation in S. aureus is an efficient immune escape mechanism.
The interplay between the NOD2 and TLR2 pathways is com-
plex, and interactions between both receptors seem to contribute
to activation or inhibition of the immune system (21). NOD2 was
shown to be part of an inhibitory system which blocks TLR2-
mediated inflammation, resulting in less Th1 cytokine production
after stimulation (22). Additionally, activation of mouse perito-
neal macrophages with the NOD2 ligand MDP resulted in down-
regulation of TLR2/1 signaling-mediated IL-1 expression (23).
However, different studies suggest a synergistic role for NOD2
and TLR2 (24).
Additionally, it is still controversially discussed whether PGN
interacts with TLR2. PGN isolated from either Gram-negative or
Gram-positive bacteria is reported not to be sensed by TLR2 (25).
However, stimulation of primary mouse keratinocytes (MKs)
with PGNpol from S. aureus SA113 resulted in internalization of
the molecule and colocalization with NOD2 and TLR2 receptors
and induced subsequent host immune responses (26). Addition-
ally, lipoproteins of S. aureus have been shown to activate TLR2
(26–29).
To further elucidate the interaction between the NOD2 and
TLR2pathways, we investigated the innate immune sensing of two
different types of naturally occurring S. aureus-derived PGNpoly-
mers. PGNof S. aureus SA113 contains traces of lipoproteins. This
PGN is referred to as the wild-type PGN. The other PGNpol frac-
tion was derived from the S. aureus SA113 lgt mutant, which is
unable to lipidate prolipoproteins and whose PGNpol therefore
does not contain lipoproteins (30).
By studying the effects of PGNpol from the wild type and that
from the lgt mutant (PGNpollgt) on DC maturation and acti-
vation as well as cytokine secretion, we showed that PGNpol is a
potent stimulator of the immune system, through both NOD2
and TLR2, while PGNpollgt, as a selective NOD2 ligand, does
not induce host immune responses. However, the addition of the
synthetic TLR2 ligand Pam3Cys (P3C) to PGNpollgt resulted in
activation of the host immune response. Costimulation with the
NOD2 ligand PGNpollgt and the TLR2 ligand P3C had a syner-
gistic effect on cytokine production, suggesting that NOD2-de-
pendent activation ofDCswith PGN requires TLR2 costimulation
by lipoproteins.
MATERIALS AND METHODS
Animals. C57BL/6 mice were purchased from Charles River (Sulzfeld,
Germany). NOD2/ mice were a kind gift from Tilo Biedermann (De-
partment of Dermatology, Eberhard Karls University, Tübingen, Ger-
many). All mice were housed under specific-pathogen-free conditions at
the animal facilities of the University of Tübingen according to German
law and European guidelines. All experiments were approved by the local
authorities (Regierungspräsidium Tübingen; Anzeigenummer 1.12.11).
Isolation of BMDCs. Bone marrow-derived dendritic cells (BMDCs)
were isolated by flushing the bone marrow from the femurs and tibias of
8- to 14-week-old WT and NOD2/ mice according to a previously
described method (31), with minor modifications.
Cells were harvested at day 8 and used to evaluate the effects of stim-
ulation with different bacterial PGN products on cytokine release and
expression of surface markers, as described below.
Stimulation of BMDCs. DCs were stimulated with different ligands,
e.g., P3C for TLR2, lipopolysaccharide (LPS) for TLR4, or MDP and
PGNpollgt for NOD2, or stimulated with the combined NOD2 and
TLR2 ligand PGNpol, at a dose of 1 g/ml if not otherwise mentioned.
The different PGN types were used at a concentration of 10 g/ml if not
otherwise mentioned. After 24 h, supernatants were harvested and ana-
lyzed for tumor necrosis factor alpha (TNF-), IL-6, and IL-12p40 cyto-
kine concentrations. Additionally, the expression of DC activation and
maturation surface markers major histocompatibility complex class II
(MHC-II) and CD40 was determined by flow cytometry.
Cytokine analysis by ELISA. Concentrations of murine IL-6, IL-8,
IL-12p40, and TNF- in cell culture supernatants were measured by en-
zyme-linked immunosorbent assay (ELISA) according to the manufac-
turer’s protocol (BD Bioscience, Heidelberg, Germany).
Fluorescence-activated cell sorter (FACS) analysis. Immature DCs
were harvested and stimulated for 24 h with different NOD2 or TLR
ligands. Cells were washed with phosphate-buffered saline (PBS) and 1%
fetal calf serum (FCS). Fc-Block was used to prevent nonspecific binding
of antibodies. DCswere incubated for 30min at 4°Cwith a fluorochrome-
conjugated antibody. The following antibodies were used for staining:
allophycocyanin-conjugated anti-mouse CD11c, fluorescein isothiocya-
nate (FITC)-conjugated anti-mouse CD40, CD80, and CD86, phyco-
erythrin (PE)-conjugated anti-mouse TLR2 and TLR4 (all antibodies
from BD Pharmingen), and appropriate isotype controls. After another
washing step (twice), the cells were fixed with 4% paraformaldehyde
(PFA). A total of 5 	 104 cells were analyzed using a FACS LSR Fortessa
flow cytometer (BD Bioscience, Heidelberg, Germany). Data were ana-
lyzed with FlowJo 7.6.4 (TreeStar Inc.).
Culture and stimulation of J774 cells andMM6 cells. J774 cells were
grown in VLE-RPMI 1640 medium with stable glutamine (Biochrom,
Berlin, Germany), 10% FCS, 1% nonessential amino acids, 1% sodium
pyruvate, and 0.5%mercaptoethanol. A total of 1 	 106 cells were seeded
perwell and incubated for 1 h. J774 cells were stimulatedwith Pam3Cys or
PGNpollgt for 48 h. After stimulation, supernatants were collected, and
cytokine (TNF-) concentrations were determined by ELISA (BD Biosci-
ence, Heidelberg, Germany). Mono Mac 6 (MM6) cells were cultured in
VLE-RPMI 1640 medium with stable glutamine (Biochrom, Berlin, Ger-
many), 10% FCS, 1% nonessential amino acids, and 1% penicillin-strep-
tomycin. After stimulation of the Mono Mac 6 cells with Pam3Cys and
PGNpollgt for 48 h, the supernatants were collected, and the concentra-
tion of IL-8 was analyzed by use of an ELISA kit (BD Biosciences) accord-
ing to the manufacturer’s instructions.
Strains and growth conditions. Staphylococcus aureus SA113 (wild
type) and the lgt mutant (no expression of mature lipoproteins) were
grown in tryptic soy broth (Sigma, Steinheim, Germany) at 37°C with
aeration for 16 h. The optical density at 578 nm was 12 (He
ios  spec-
trophotometer; Thermo Scientific).
Isolation of polymeric peptidoglycan (PGNpol). The isolation of ul-
trapure PGN, free ofDNA,RNA, proteins, wall teichoic acids, lipoteichoic
acids, and salts, was done according to the method of de Jonge et al. (32),
with somemodifications. Thesemodifications included the usage of three
different buffers (buffers A to C). The pellet of a 50-ml overnight culture
was boiled in 10 ml buffer A (2.5% SDS in 0.1 M Tris-HCl, pH 6.8) for 20
min at 100°C. The SDS was removed by several washing steps with dou-
ble-distilled water at 4,700 rpm at room temperature. The pellet was re-
suspended with 20 ml 0.1 M Tris-HCl, pH 6.8. Cells were disrupted by
vortexing with glass beads (150 to 212 m). The supernatant was subse-
quently incubated with buffer B for 1 h (10 g/ml DNase and 50 g/ml
RNase in 0.1 M Tris-HCl, pH 6.8), with buffer C overnight (50 g/ml
trypsin in double-distilled water), and, finally, with hydrofluoric acid
(HF) for 4 h.HFwaswashed outwith double-distilledwater, and the PGN
was lyophilized overnight.
Lyophilized PGN (10mg/ml) was digested with 500 Umutanolysin of
Streptomyces globisporus ATCC 21553 (Sigma) in a 12.5 mM phosphate
buffer (pH 5.5) at 37°C for 16 h. The sample was boiled for 3 min and
centrifuged for 5 min at 10,000 rpm. The supernatant was reduced with
sodium borohydride in 0.5 M borate buffer (pH 9) for 20 min at room
Schäffler et al.
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temperature. The pH was subsequently adjusted to 2 with orthophos-
phoric acid. Samples were further processed or stored at 20°C.
The separation and analysis of the peptidoglycan polymer were per-
formed by high-pressure liquid chromatography (HPLC), based on the
method of Glauner (33), using an Agilent 1200 analytical HPLC system. A
250- by 4.6-mm reversed-phase column (Prontosil 120-3-C18 AQ;
Bischoff) guarded by a 20- by 4.6-mm precolumn was used. The samples
were eluted at a flow rate of 0.5 ml/min, using a linear gradient starting
from 100% buffer A (100mMNaH2PO4, 5% [vol/vol] methanol, pH 2.5)
to 100% buffer B (100 mM NaH2PO4, 30% [vol/vol] methanol, pH 2.8)
within 155 min. The column temperature was set to 52°C. The eluted
muropeptides were detected by UV absorption at 205 nm. The corre-
sponding polymer peak (rt  105 to 135 min) (Fig. 1) was collected and
desalted on the same column, using a water-acetonitrile gradient.
LPS contamination was checked using an Endosafe-PTS system
(Charles River, Sulzfeld, Germany). Remaining LPS impurities were re-
moved using an EndoTrapRed endotoxin removal kit (Hyglos). Very low
LPS contents could be detected (0.005 endotoxin unit [EU]/mg).
Statistical analysis. Statistical analysis was performed using Graph-
Pad Prism software (GraphPad, La Jolla, CA). Parameters were analyzed
by a nonparametric one-way analysis of variance (ANOVA) model for
repeated measurements, with the Bonferroni adjustment (*, P  0.05; **,
P  0.01; and ***, P  0.001). P values of 0.05 were considered signif-
icant. Error bars represent standard errors of the means (SEM). If not
otherwise mentioned, figures show means  SEM of values from three
experiments per group. StimulatedDCs fromWTmice were compared to
unstimulated DCs from WT mice, and stimulated DCs from NOD2/
mice were compared to unstimulated DCs from NOD2/ mice.
RESULTS
Purification of polymeric peptidoglycan (PGNpol) from S. au-
reus and its lgt mutant. To address the importance of lipopep-
tide impurities within the PGN fractions in signaling, we isolated
polymeric PGN from two S. aureus SA113 strains. On the one
hand, we isolated PGN fromwild-type SA113, containing residual
mature lipoproteinswithin the polymeric PGNmeshwork.On the
other hand, we isolated PGN from SA113 lgt, which is consid-
ered lipoprotein free because of its inability to produce mature
lipoproteins. A typical pattern for PGN from WT SA113 after
muramidase digestion is shown in Fig. 1. The pattern for PGN
from SA113 lgt was identical to the WT pattern and is therefore
not shown.
Activation and maturation of DCs by PGNpol are due to re-
sidual lipoproteins. In order to elucidate the role of S. aureus-
derived polymeric PGN in the NOD2-mediated activation of
BMDCs, these cells were stimulatedwith PGN isolated fromeither
WT S. aureus SA113 (PGNpol) or SA113 lgt (PGNpollgt).
PGNpol is a ligand of NOD2, but while PGNpollgt is lipoprotein
free, the PGNpol preparation contains lipoproteins of S. aureus,
which are known to be ligands of TLR2 (30).
For control purposes, Pam3Cys (a synthetic triacylated lipo-
peptide), LPS, and MDP were used as specific ligands for TLR2,
TLR4, andNOD2, respectively. Incubation ofDCswith increasing
concentrations of PGNpollgt (up to 100 g/ml) did not stimu-
late secretion of IL-6, as indicated in Fig. 2A. In contrast, PGNpol
(10g/ml) strongly stimulated IL-6 secretion, to a degree that was
comparable with that induced by LPS or Pam3Cys. Furthermore,
incubation with PGNpollgt (up to 100 g/ml) did not induce
secretion of IL-12p40 (Fig. 2B), while PGNpol (10 g/ml)
strongly stimulated IL-12p40 secretion.
In order to find out whether PGNpol and PGNpollgt lead
to DC maturation, DCs were stimulated with PGNpollgt or
PGNpol and afterwards analyzed for MHC-II and CD40
FIG 1 Separation and analysis of polymeric PGN. Separation and analysis of the peptidoglycan polymer were performed using an Agilent 1200 analytical HPLC
system. The corresponding polymer peak (rt  105 to 135 min) was collected and desalted. Remaining LPS impurities were removed. Shown is the pattern for
muramidase-digested PGN from an S. aureus SA113 wild-type overnight culture. The boxed sequence indicates the collected polymeric PGN fragments.
Synergistic Effect of PGN and Lipoproteins on DCs
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surface expression by flow cytometry. DCs stimulated with
PGNpol expressed high levels of MHC-II and CD40, resulting
in highly activated and mature DCs. In contrast, expression of
these surface molecules was nearly unaffected in DCs exposed
to PGNpollgt, suggesting a reduced ability of PGNpollgt to
activate and mature DCs (Fig. 3).
Stimulation with PGNpol leads to increased activation and
maturation of DCs compared to the case with PGNpollgt. To
further elucidate the effect of a bacterial NOD2 ligand and the
potentially costimulatory effect of a TLR2 ligand, DCs from
NOD2/ mice were compared to DCs fromWT mice.
First, secretion of IL-12p40 was tested after stimulation with
PGNpollgt and PGNpol. Consistent with the data shown in Fig.
2A, therewas nodetectable secretion of IL-12p40 after stimulation
with PGNpollgt inDCs from eitherWTmice orNOD2/mice.
In contrast, stimulation with PGNpol induced a significantly
smaller IL-12p40 signal in DCs fromNOD2/ mice than in DCs
from WT mice (Fig. 4). These data strongly suggest that a com-
bined NOD2 and TLR2 signal is necessary to induce a strong se-
cretion of IL-12p40 and that the smaller signal in the DCs from
NOD2/ mice was the result of the sole activation of TLR2. Sim-
ilar results were obtained with IL-6 after stimulation of DCs from
NOD2/ mice with PGNpollgt and PGNpol (data not shown).
To further test the effect of combined TLR2 and NOD2 stimula-
tion onDCactivation andmaturation, we analyzed the expression of
the DC surface markers MHC-II and CD40 by flow cytometry. In
NOD2/ DCs, incubation with PGNpol led to a significantly
smaller proportion of MHC-IIhigh cells than the case in stimulated
WT DCs (Fig. 5A). Furthermore, there was an increased expression
of CD40 in DCs after stimulation with PGNpol compared to
PGNpollgt (Fig. 5B). Taken together, our data strongly suggest
that a combined stimulation of the TLR2 and NOD2 pathways by
PGNpol is important for the activation andmaturation of DCs.
Combined stimulation of DCs with PGNpollgt and
Pam3Cys reveals synergistic effects onTNF- secretionpattern.
TNF- is a key cytokine in IBD and is well known for its role in
mediating innate immune responses (34). To confirm our hy-
pothesis that combined stimulationwith TLR2 andNOD2 ligands
FIG 2 Stimulation with PGNpol, but not PGNpollgt, leads to significant secretion of IL-6 and IL-12p40 in DCs. Incubation of DCs with PGNpol, but not
PGNpollgt, stimulated IL-6 (A) and IL-12p40 (B) secretion, which was comparable to that induced by LPS or Pam3Cys. DCs were stimulated with PGNpollgt
at concentrations of up to 100 g/ml. Stimulation with 10 g/ml PGNpol led to high levels of secretion of IL-6 and IL-12p40. A comparison was made between
unstimulated cells and each stimulant by using a nonparametric one-way ANOVA model for repeated measurements, with the Bonferroni adjustment. ns, not
significant.
FIG 3 Stimulation with PGNpol, but not PGNpollgt, leads to increased MHC-II and CD40 expression in DCs. Immature BMDCs were activated with several
NOD2 or TLR2 ligands. Maturation was quantified by FACS analysis to assess the levels of MHC-II (A) and CD40 (B). The quantification was based on isotype
controls. Stimulation of DCs with PGNpol (10g/ml) led to strongMHC-II and CD40 signals. In contrast, stimulation of DCs with PGNpollgt (10g/ml) did
not lead to increased expression of MHC-II and CD40. A comparison was made between unstimulated cells and each stimulant by using a nonparametric
one-way ANOVA model for repeated measurements, with the Bonferroni adjustment.
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acts synergistically on DC cytokine secretion, we costimulated
DCs with the NOD2 ligand PGNpollgt and the TLR2 ligand
Pam3Cys and determined the secretion of TNF-. In line with our
hypothesis, the costimulation induced a significantly enhanced
expression of TNF- inDCs compared to the case in PGNpollgt-
or P3C-monostimulated DCs (Fig. 6).
To further confirm these findings, the experiments were ex-
tended to additional immune cells, i.e., a murine macrophage cell
line (J774 cells) (Fig. 7) and a human monocyte cell line (MM6
cells) (Fig. 8). In both cell lines, the synergistic costimulation with
PGNpollgt and P3C resulted in an increased expression of pro-
inflammatory cytokines, indicating that the observed effect is not
restricted tomouseDCs but seems to be relevant for the activation
of different types of innate immune cells.
DISCUSSION
NOD2mutations play an important role in Crohn’s disease (1, 2).
However, how exactly these mutations contribute to this specific
disease still remains uncovered. NOD2, as an important intracel-
lular receptor of the innate immune system, senses bacterial cell
wall products, such as MDP, and activates NF-B (35). While
MDPwas the first NOD2 ligand described (36, 37), it later became
clear that polymeric (16, 38) as well as monomeric (14) PGN also
activates NOD2. DCs are the most potent APCs in the intestinal
mucosa and have important functions in the mucosa-associated
immune system (39). Because of their important role in activating
and also regulating the immune system, they also seem to play an
important role in Crohn’s disease (11). Therefore, we studied the
role of NOD2-mediated activation of DCs via natural S. aureus-
derived PGN. In the present study, we focused on the role of poly-
meric PGN, which is an important part of the bacterial cell wall.
Defined isogenic S. aureus mutant strains were used to elucidate
the effect of NOD2 ligand (PGNpollgt) monostimulation or the
synergistic effect of NOD2 and TLR2 ligand (PGNpol) costimu-
lation. While monostimulation with a natural NOD2 ligand
(PGNpollgt) did not lead to activation and maturation of DCs,
costimulation with a NOD2 and TLR2 ligand (PGNpol) led to
strong activation and increased cytokine secretion (IL-6 and IL-
12p40) ofDCs in vivo. This effect was seen not only in isolatedDCs
but also in J774 cells (macrophages) andMM6 cells (monocytes).
In addition to already published work by Müller-Anstett et al.
(26), our data indicate that singular NOD2 activation seems to
FIG 4 Stimulation with PGNpol in DCs is dependent on a NOD2 costimulus. Stimulation with PGNpol led to significantly increased secretion of IL-6 (A) and
IL-12p40 (B) in DCs from WT mice compared to unstimulated controls. In contrast, DCs derived from NOD2/ mice failed to show increased IL-6 and
IL-12p40 secretion upon stimulation with PGNpol. Stimulated DCs from WT mice were compared to unstimulated DCs from WT mice, and stimulated DCs
from NOD2/ mice were compared to unstimulated DCs from NOD2/ mice.
FIG 5 DC stimulation with PGNpol in WTmice leads to increased expression of MHC-II and CD40 compared to that in NOD2/ mice. Stimulation of DCs
fromNOD2/mice with PGNpol (10g/ml) did not lead to significantlymore expression ofMHC-II (A) or CD40 (B), indicating that the costimulatory effect
of NOD2 and TLR2 is necessary for effective maturation of DCs. Stimulated DCs from WT mice were compared to unstimulated DCs from WT mice, and
unstimulated DCs from NOD2/ mice were compared to stimulated DCs from NOD/ mice. In addition, a comparison between DCs from WT and
NOD2/ mice was made by using a nonparametric one-way ANOVA model for repeated measurements, with the Bonferroni adjustment.
Synergistic Effect of PGN and Lipoproteins on DCs
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play aminor role in activating immune cells. However, synergistic
costimulation of the NOD2 and TLR2 pathways results in potent
activation of DCs, macrophages, and monocytes.
In patients withCrohn’s disease, an exaggerated Th1-mediated
immune response may contribute to mucosal inflammation (40).
In vivo, MDP itself is not able to induce a Th1 cytokine profile but
rather invokes a Th2 immune response (41). Additionally, in sup-
port of our results, it has been demonstrated that combined stim-
ulation withMDP plus a TLR2 or TLR4 ligand leads to a synergis-
tic release of IL-6 and IL-12p40 in BMDCs, which is abolished in
NOD2/ DCs (41). While stimulation of the innate immune
system with a sole NOD2 ligand, in our case S. aureus-derived
polymeric PGNpollgt, does not lead to an immune response,
such a response is markedly enhanced after dual stimulation via
the NOD2 and TLR2 pathways. The complex interplay between
NOD2 and TLR2 signaling might have an influence on intestinal
homeostasis.
However, how can these results be translated into the clinical
entity of Crohn’s disease? Activation of NOD2 by MDP protects
mice from experimental colitis (42), thus promoting intestinal
homeostasis. Additionally, PGN from specific lactobacilli features
anti-inflammatory effects and thus seems to be crucial for the
probiotic action of these specific strains (43). These studies further
support the hypothesis that stimulation of NOD2 alone—as op-
FIG 6 Combined stimulation of DCs with NOD2 and TLR2 ligands leads to stronger secretion of IL-12p40 and TNF than stimulation with each of the
stimuli alone. DCs were stimulated with PGNpollgt (10 g/ml), Pam3Cys (1 g/ml), and LPS (1 g/ml). After stimulation with both PGNpollgt and
Pam3Cys, there were significantly higher signals for IL-12p40 (A) and TNF (C) than the case for stimulation with the single components alone. (B) There
was not a significantly higher signal of IL-6 than that for stimulation with the single components. Unstimulated DCs from WT mice were compared to
stimulated DCs from WT mice by using a nonparametric one-way ANOVA model for repeated measurements, with the Bonferroni adjustment.
FIG 7 Combined stimulation of J774 cells with NOD2 and TLR2 ligands
leads to significant TNF- secretion. J774 cells were stimulated with
Pam3Cys (1 ng/ml), PGNpollgt (10 g/ml), PGNpol (10 g/ml), and LPS
(1 g/ml) for 48 h. After stimulation with both PGNpollgt and Pam3Cys,
there was a significant increase of TNF-, which seemed to be higher than
stimulation with the single components. Unstimulated DCs fromWTmice
were compared to stimulated DCs fromWTmice by using a nonparametric
one-way ANOVA model for repeated measurements, with the Bonferroni
adjustment.
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posed to costimulation of NOD2 and TLR2—can possibly lead to
downregulation of inflammatory pathways. A “loss of function”
in the NOD2 gene might therefore be an important part of the
pathogenesis of Crohn’s disease.
In summary, we showed that in DCs, synergistic costimulation
of the NOD2 and TLR2 signaling cascades leads to an increased
activation and maturation of DCs, and also to increased cytokine
secretion, compared to the case with monostimulation. These re-
sults might be important for a better understanding of the com-
plex interplay between these receptors in maintaining homeosta-
sis in the intestinal immune system.
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SUMMARY
Skin is constantly exposed to bacteria and antigens,
and cutaneous innate immune sensing orchestrates
adaptive immune responses. In its absence, skin
pathogens can expand, entering deeper tissues
and leading to life-threatening infectious diseases.
To characterize skin-driven immunity better, we
applied living bacteria, defined lipopeptides, and
antigens cutaneously. We found suppression of im-
mune responses due to cutaneous infection with
Gram-positive S. aureus, which was based on bacte-
rial lipopeptides. Skin exposure to Toll-like receptor
(TLR)2-6-binding lipopeptides, but not TLR2-1-
binding lipopeptides, potently suppressed immune
responses through induction of Gr1+CD11b+
myeloid-derived suppressor cells (MDSCs). Investi-
gating human atopic dermatitis, in which Gram-pos-
itive bacteria accumulate, we detected high MDSC
amounts in blood and skin. TLR2 activation in skin
resident cells triggered interleukin-6 (IL-6), which
induced suppressive MDSCs, which are then re-
cruited to the skin suppressing T cell-mediated recall
responses such as dermatitis. Thus, cutaneous bac-
teria can negatively regulate skin-driven immune re-
sponses by inducing MDSCs via TLR2-6 activation.
INTRODUCTION
The skin is the largest organ at the interface between the environ-
ment and the host. The skin plays a major protective role not
only as physical barrier but also as the site of first recognition
of microbes and orchestrates consecutive immune responses
(Naik et al., 2012; Swamy et al., 2010; Volz et al., 2012).
Staphylococcus aureus (S. aureus) is one of the most potent
skin pathogens and is found to colonize skin of about 30%–
50% of healthy adults, among them 10%–20% persistently
(Lowy, 1998). Coming from the skin, S. aureus can infect any tis-
sue of the body and cause life-threatening diseases, particularly
because of the widespread occurrence of antibiotic-resistant
strains, known as methicillin-resistant Staphylococcus aureus
(MRSA) (Saeed et al., 2014). In atopic dermatitis (AD) patients,
there is an approximately 200-fold increase of S. aureus coloni-
zation with more than 90% of AD patients displaying S. aureus in
comparison to the healthy skin (Leung and Bieber, 2003).
Microbes are first sensed by the innate immune system
through pattern-recognition receptors (PRRs), which recognize
microbe-associated molecular patterns (MAMPs) (Kawai and
Akira, 2010). Both epithelial cells and resident innate immune
cells in the skin express PRRs (Kupper and Fuhlbrigge, 2004;
Lai and Gallo, 2008). Among PRRs, Toll-like receptors (TLRs)
are a well-characterized family with distinct recognition profiles
(Kawai and Akira, 2010). TLR2 has emerged as a dominant re-
ceptor for Gram-positive bacteria, especially S. aureus (Bieder-
mann, 2006; Lai and Gallo, 2008; Mempel et al., 2003). Among
TLR2 ligands, lipoproteins seem to be especially important
because the lipoprotein diacylglyceryl transferase (lgt) deletion
mutant of S. aureus induces much less proinflammatory cyto-
kines in human cell lines (Stoll et al., 2005) and less TLR2-
MyD88 adaptor protein-mediated inflammation in a mouse
model of systemic infection (Schmaler et al., 2009). It is now es-
tablished that there are different classes of lipopeptides that all
bind TLR2 (Mu¨ller et al., 2010; Schmaler et al., 2009). However,
how these TLR2 ligands differ in regard to functional conse-
quences has not been thoroughly investigated. TLR2 is known
to form heterodimers with TLR1 and TLR6 to interact with this
broad spectrum of ligands (Kang et al., 2009). TLR1 is required
as a coreceptor for recognition of triacylated lipopeptides,
such as Pam3Cys (Buwitt-Beckmann et al., 2006; Jin et al.,
2007), while diacylated lipopeptides, such as FSL-1 or
Pam2Cys, interact with TLR2-TLR6 heterodimers (Mae et al.,
2007; Mu¨hlradt et al., 1997). Functional properties of S. aureus
lipopeptides in respect to TLR2 heterodimers have been investi-
gated in several cell types (Buwitt-Beckmann et al., 2006; Hajjar
et al., 2001), but evidence demonstrating specific functional
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consequences for the activation of different heterodimers in vivo
is lacking.
Sustained activation of TLRs causes persistent production of
proinflammatory cytokines, such as tumor necrosis factor
(TNF) or interleukin-6 (IL-6), leading to tissue damage (Kawai
and Akira, 2010; Kupper and Fuhlbrigge, 2004; Lai and Gallo,
2008). Consequently, to reconstitute the integrity of the surface
organ, mechanisms to limit cutaneous inflammation must be
effective (Lai et al., 2009). In recent years, Gr1+CD11b+
myeloid-derived suppressor cells (MDSCs) have been identified
as one cell population responsible for modulating immune re-
sponses (Bronte, 2009; Gabrilovich and Nagaraj, 2009; Os-
trand-Rosenberg and Sinha, 2009). The most characteristic
functional property of MDSCs is to suppress T cell responses
(Gabrilovich et al., 2001; Kusmartsev et al., 2000). In the context
of inflammation the precise function of MDSCs and the mecha-
nisms of MDSC induction are not well-understood; but in a
sepsis model with Gram-negative bacteria their induction has
been shown to depend on TLR4-MyD88 activation (Delano
et al., 2007), and in tumor models, different innate cytokines,
such as IL-6, induce MDSC accumulation (Bunt et al., 2007;
Chalmin et al., 2010). However, the suppression of IL-6 also
increases susceptibility to bacterial and fungal infections, indi-
cating pleiotropic effects of IL-6 (Hoetzenecker et al., 2012).
In this study, we have identified a pathway of immune regula-
tion that operates in the skin. We mimicked intense cutaneous
contact to bacteria in different in vivo mouse models by using
living bacteria and lipopeptides. We investigated AD as a model
for massive cutaneous immune sensing of Gram-positive bacte-
ria in humans. We found that cutaneous infection with S. aureus
caused immune suppression. The exposure to TLR2-6 ligands
was sufficient to cause an almost complete reduction of consec-
utive cutaneous recall responses. This skin exposure induced
accumulation of MDSCs, allowing MDSC recruitment to the
skin, and suppression of T cell-mediated recall responses. Sig-
nals through TLR2 on skin-resident cells, but not on recruited
hematopoietic cells, as well as cutaneous IL-6 induction, were
necessary and sufficient for the expansion of MDSCs and
consecutive immune suppression. These data demonstrate
that cutaneous recognition of TLR2-6 ligands orchestrates a
unique pathway of cutaneous immune modulation mediated
by MDSCs, indicating a yet unknown level of immune
counterregulation.
RESULTS
Cutaneous Staphylococcus aureus Induces
Immune Suppression
We aimed to characterize the consequences of intense cuta-
neous innate immune sensing as in the case of colonization or
infection with Gram-positive bacteria. We established a mouse
model of epicutaneous colonization with pathologically relevant
S. aureus (Wanke et al., 2013). Mimicking S. aureus skin infection
by applying living S. aureus bacteria onto the skin with disrupted
skin barrier, we found a distribution of the bacteria not only in the
skin but also in the internal organs (spleen and kidney) (Fig-
ure 1A), indicating the importance of the skin as an effective
defense immune organwith the potential to impact the whole im-
mune system. To investigate how bacterial infection influences
consecutive immune responses, we combined this model of
bacterial colonization and the murine T cell-mediated contact
hypersensitivity (CHS) to FITC, in which bacteria were applied
epicutaneously during FITC re-exposure of FITC-sensitized
mice (see protocol in Figure S1A available online). The applica-
tion of FITC onto the ear led to FITC-specific dermatitis as deter-
mined by ear swelling, which corresponded to the strength of the
FITC-specific immune response. The cutaneous application of
S. aureus 7 days previous to the FITC challenge did not enhance,
but significantly reduced ear swelling and immune cell infiltration
(Figures 1B and 1C). This immune suppression was completely
dependent on immune sensing of bacterial lipoproteins, as lipo-
protein-deficient S. aureus mutant (Dlgt) (Stoll et al., 2005) failed
to induce immune suppression. Injecting S. aureus into the sub-
epithelial dermis (intracutaneous route) also induced consecu-
tive immune suppression, which, however, tended to be weaker
compared to effects of S. aureus application onto the epithelium
(Figure S1B). To identify underlying mechanisms of S. aureus-
induced cutaneous immune suppression, we analyzed skin-
draining lymph nodes. Only exposure to wild-type (WT)
S. aureus bacteria and not the lipoprotein-deficient Dlgt S.
aureus reduced ex vivo FITC-specific T cell proliferation (Fig-
ure 1D). In the spleen, CD4+ and CD8+ T cells were also reduced
in mice cutaneously exposed to WT S. aureus, but not in mice
exposed to lipoprotein-deficient Dlgt S. aureus (Figure 1E).
Only in mice displaying suppressed T cells we detected a
strong increase of Gr1+CD11b+ so-called myeloid-derived sup-
pressor cells (Figure 1E). In contrast to this, accumulation of
Gr1+CD11b+ was not detected in the liver (Figure S1D). At day
3 after FITC challenge, MDSCs were also slightly increased in
draining lymph nodes due to cutaneous WT S. aureus infection,
corresponding to the decrease of proliferating Ki67+ T cells (Fig-
ure S1E). Further experiments investigating other suppressive
cell populations showed no alterations in the number of regula-
tory T (Treg) cells and IL-10-producing cells (Figure S1F); the
numbers of Langerhans cells (LCs, defined as CD11cloCD205hi)
and CD11c+MHC-II+ cells were also unchanged, and dermal
dendritic cells (dDCs, defined as CD11chiCD205lo) were slightly
increased (Figure S1E). These data indicate thatMDSCs function
independently of Treg cells and do not inhibit migration of DCs
into lymph nodes.
In order to further emphasize the functional and clinical rele-
vance of these findings, we investigated atopic dermatitis (AD)
patients. AD is a perfectly suited model disease for investiga-
tions on immune consequences of skin exposure to bacteria,
because AD is an inflammatory skin disease that is nearly always
covered with and triggered by Staphylococci. In humans,
MDSCs are typically described as CD11b+CD33+HLA-DR
CD14 cells (Gabrilovich and Nagaraj, 2009). We observed a
significant increase of MDSCs in the peripheral blood mononu-
clear cells (PBMCs) of AD patients (Figure 1F). The upregulation
of human MDSCs was especially consistent in patients, in which
severe AD was complicated by eczema herpeticum, which is a
severe cutaneous viral infection resulting from immune suppres-
sion (Figure 1F, red squares) (Beck et al., 2009; Wollenberg
et al., 2003), suggesting suppressive properties of MDSCs
also in AD patients.
These data show that cutaneous S. aureus is sufficient to
induce MDSCs and to cause immune suppression.
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Cutaneous Exposure to TLR2-6 but Not to TLR2-1
Ligands Ameliorates T Cell-Mediated Recall Responses
Next, we investigated the intriguing finding that lipoprotein-defi-
cient S. aureus failed to induce immune suppression in our model
(Figure 1B). As lipoproteins are sensed by different TLR2 hetero-
dimers (Henneke et al., 2008), we have taken advantage ofmicro-
bial-derived molecules, which are exclusively bound by one
specific TLR2 heterodimer. We selected three lipopeptides for
our studies: TLR2-6 ligands diacyl lipopeptides FSL-1 and
Pam2Cys and the triacylated lipopeptide Pam3Cys that is often
used as a reference compound for TLR2-1 activation. As in our
previous model, lipopeptides were applied to the skin during
re-exposure of FITC-sensitized mice to FITC (see protocol Fig-
ure S1A). Similarly to the livingS. aureus, the cutaneous exposure
to TLR2-6 ligand FSL-1 almost completely abrogated consecu-
tive FITC-specific recall responses (Figures 2A and 2B), FITC-
specific ex vivo T cell proliferation (Figure 2C) and orchestrated
splenic reduction of CD4+ and CD8+ T cells together with
MDSC accumulation (Figure 2D). This result was confirmed
with another TLR2-6 ligand, Pam2Cys (Figures 2E–2H). In
contrast to Pam2Cys, the TLR2-TLR1 ligand Pam3Cys failed to
suppress FITC-specific dermatitis and T cell proliferation (Figures
2E–2G). Accordingly, no reduction of CD4+ and CD8+ T cells and
no induction of Gr1+CD11b+ cells could be detected (Figure 2H).
These data show that cutaneous exposure to bacterial TLR2-
TLR6 ligands is sufficient to cause immune suppression and that
Figure 1. Cutaneous Staphylococcus aureus Induces Immune Suppression in Mice and Humans
(A–E) FITC-sensitized WT mice were treated following the protocol in Figure S1A (with living WT or lipoprotein mutant (Dlgt) S. aureus). Bacterial load as colony-
forming units (cfu) (mean ± SD, n = 5) (A), ear swelling (mean ± SD, n = 5) (B), histology (H&E staining) (C), proliferation of skin-draining lymph node (LN) cells
stimulated ex vivo with FITC (detected as counts per minute [cpm] of 3H-thymidine incorporation) (mean ± SD of triplicates) (D), and the percentage of cell
populations in the spleen (mean ± SD, n = 5) (E) were investigated. *p < 0.05.
(F) PBMCs from atopic dermatitis (AD) patients (n = 33) and healthy volunteers (n = 30) were analyzed forMDSCs, defined asCD11b+CD33+HLA-DRCD14 cells.
The dots represent individual values, and the horizontal bar is the groupmean. Red squares representMDSCs of patients with severe ADand eczema herpeticum.
*p < 0.05 (Mann-Whitney test). Data are representative of at least two independent experiments. See also Figure S1.
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Figure 2. Cutaneous Exposure to TLR2-6 but Not TLR2-1 Ligands Ameliorates T Cell-Mediated Recall Responses of the Skin
WT mice were treated following the protocol shown in Figure S1A. Mice were cutaneously exposed to FSL-1 in (A)–(D) and Pam2Cys or Pam3Cys in (E)–(H). Ear
swelling response (mean ± SD, n = 5) (A and E), histology (H&E staining) (B and F), proliferation of skin-draining LN cells stimulated ex vivo with FITC (mean ± SD
of triplicates) (C and G), and the percentage of cell populations in the spleen (mean ± SD, n = 5) (D and H) are shown. Data are representative of at least two
independent experiments. Experiments shown in (A) were performed with FSL-1 from two different providers. *p < 0.05.
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activation of TLR2-TLR6 heterodimers differs in regard to
functional consequences from activation of TLR2-TLR1
heterodimers.
Further, in order to control whether the presentation of the
antigen FITC is directly influenced by Pam2Cys exposure, we
analyzed the number of FITC positive DCs 14 hr after cutaneous
FITC application and Pam2Cys exposure. There were no differ-
ences in the numbers of FITC positive CD11c+MHC-II+ cells
and other dendritic cell populations (dDCs, LCs) in draining
lymph nodes (Figure S1G). Similarly, the analysis of other cell
populations at this early stage of the response revealed com-
parable numbers of T cells (CD4+, CD8+), activated T cells
(CD4+CD25+) and proliferating cells (Ki67+) (Figure S1H), IL-10
producing cells, and Treg cells (Figure S1I) in both mouse
groups. The treatment of mice with cyclophosphamide for Treg
cell depletion failed to reverse Pam2Cys-induced immune sup-
pression (Figures S1J–S1L), further indicating that Treg cells
are not involved in this type of immune suppression.
Skin-Infection-Induced Immune Suppression Is
Mediated by Gr1+CD11b+ Myeloid-Derived
Suppressor Cells
Next, as proof of concept that MDSCs are the responsible cells
for the observed immune suppression upon cutaneous
Pam2Cys exposure, we depleted Gr1+ cells. This depletion
caused an abrogation of immune suppression (Figure 3A, right).
Inversely, the adoptive transfer of MDSCs, isolated from mice
previously exposed to Pam2Cys, resulted in reduction of both
FITC-specific dermatitis and T cell proliferation (Figures 3B and
3C). To investigate whether human MDSCs in AD patients with
intense cutaneous exposure to lipoproteins were suppressive,
we depleted CD11b+ cells from PBMCs and analyzed prolifera-
tion of activated T cells. The CD11b+ population among PBMCs
consists of antigen-presenting cells and, in addition, contains
MDSCs in AD, but not healthy individuals. Consequently, in
seven of eight healthy volunteers, CD11b depletion resulted in
reduced T cell proliferation (Figure 3D, left). On the contrary,
this was only observed in one out of 7 AD patients (Figure 3D,
right). These results demonstrate thatMDSCs, which are present
among the CD11b+ population in AD patients, but not in healthy
individuals, are immunosuppressive. Indeed, T cell receptor
z-chain was significantly downregulated in AD patients (Fig-
ure 3E), which is known to be one of the major features of
MDSC-mediated T cell inhibition (Zea et al., 2005).
Taken together, these data revealed that skin-infection-
induced immune suppression is mediated by MDSCs.
Myeloid-Derived Suppressor Cells Are Recruited to the
Skin in Mice and Humans
Detecting MDSCs in human blood and mouse spleen following
cutaneous innate immune sensing indicates systemic MDSC
expansion. Therefore, we next monitored the kinetics of MDSC
induction in mice in (1) the bone marrow (BM), its primary source
(Figure 4A, left), and (2) one site of MDSC enrichment, the spleen
(Figure 4A, right) at different time points after cutaneous
Pam2Cys exposure. Starting on day 2, Gr1+CD11b+ cells in the
BM increased and peaked at day 7 with about 75%of cells being
Gr1+CD11b+. In the spleen, both CD4+ and CD8+ T cells were
strongly reduced. Gr1+CD11b+ cells increased starting at day 4
with up to 7-fold induction on day 11 following cutaneous
Pam2Cys exposure (Figure 4A).
In FITC-CHS, T cells migrate to the skin and elicit dermatitis.
Therefore, we analyzed whether MDSCs were also recruited to
the skin. Indeed, 8 hr after FITC challenge Gr1+CD11b+ cells
were significantly increased in the skin of mice previously
exposed to Pam2Cys (Figure 4B). Similarly, we compared
healthy skin with lesional skin from AD patients colonized or in-
fected with S. aureus. Flow cytometry analysis confirmed a sig-
nificant increase of MDSCs in the skin of AD patients compared
to healthy skin (Figure 4C), indicating that presence of bacteria
and subsequent skin inflammation induce MDSC accumulation
in the skin also in humans.
Suppression of TCell Activation byMDSCs Is Induced by
Cutaneous Innate Immune Sensing
Recruitment of MDSCs to the skin suggested MDSC-mediated
suppression of T cell activation in the skin in vivo. As first indica-
tion, we found that the depletion of CD11b+ cells of isolated
skin cells caused a stronger T cell proliferation following stimula-
tion with anti-CD3-CD28 in comparison to cells not depleted of
CD11b+ cells (Figure S2A), confirming a suppressive function of
skin MDSCs ex vivo. Moreover, flow cytometry analysis of ear
skin tissue following the FITC challenge revealed a significant
decrease of CD3+ T cells (Figure 5A, right) and IFN-g production
(Figure 5A, left) in previously Pam2Cys-exposed mice. Expres-
sion analysis of other cytokines revealed a significant decrease
of the Th2 cell cytokine IL-4 (a target for a systemic AD treatment
[Beck et al., 2014]), IL-10, and a tendency for IL-17 inhibition (Fig-
ure 5B). The investigation of cutaneous chemokines in the skin
showed a downregulation of most analyzed chemokines (CCL2,
CCL3, CCL4, CCL5, CCL11, CCL13, CCL17, CCL20, CCL27).
Only T cell attracting CCL22 (a CCR4 ligand) and CCL28 (CCR3
and CCR10 ligand) were significantly upregulated (Figure 5C).
The corresponding chemokine receptors were expressed on
theMDSCs in theskin,blood, andbonemarrow (Figure5D),which
further indicates that MDSCs are attracted to the site (and by
similar mechanism) of T cell migration (Biedermann et al., 2002).
To explore the mechanisms mediating MDSC-induced im-
mune suppression, we isolated MDSCs 10 days after Pam2Cys
exposure. Flow cytometry analysis revealed the presence of
both Ly6C+ and Ly6G+MDSCs. Morphological evaluation of iso-
lated MDSCs confirmed that Ly6G+ MDSC were granulocytic,
whereas Ly6C+ MDSCs were monocytic (Figure S2B). In the
skin, Gr1+CD11b+ cells were further characterized as CD11c-,
CD15-, MHC-II-, B220-negative and positive for CD16-32 and
partly positive for F4-80 (Figure S2C), and splenic Ly6C+ cells
had a similar phenotype (Figure S2C). Next, we isolated Gr-
1dimLy6GLy6C+CD11b+ (Ly6C+) and Gr-1hiLy-6G+CD11b+
(Ly6G+) MDSCs from Pam2Cys-exposed mice and cocultured
them with naive splenocytes (responder cells) activated with
anti-CD3-CD28 antibodies (Abs) at different ratios. Following
coculture with Ly6C+ MDSCs at a ratio of 2:1, almost complete
suppression of T cell proliferation was observed, while Ly6G+
cells were not suppressive (Figure 5E, left). Investigating the sup-
pressive activity more thoroughly revealed that Ly6C+ MDSCs
inhibited Th0 CD4+ T cells, as well as Th1-, Th2-, and Th17-
polarized cells (Figure S2D). MDSCs’ immunosuppressive activ-
ity is reported to be a result of the activation of inducible NOS
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(iNOS), leading to increased production of nitric oxide (NO) (Ga-
brilovich et al., 2001). Indeed, we found an increased iNOS
expression in the skin after FITC challenge in Pam2Cys-exposed
mice (Figure S2E), and Ly6C+ MDSCs from Pam2Cys-exposed
animals produced high concentration of NO (Figure 5E, middle).
NO production and T cell suppression by Ly6C+ MDSCs was
completely abrogated in a transwell experiment (Figure 5E mid-
dle, Figure S2F), indicating thatMDSC activation is a prerequisite
for MDSC NO production and MDSC-mediated suppression.
Flow cytometry analysis of the coculture confirmed higher
expression of iNOS by Ly6C+ cells (with a very low expression
of arginase and IL-10 by both MDSC subsets) (Figure S2G). In
Figure 3. Myeloid-Derived Suppressor Cells Are Responsible for Skin-Infection-Induced Immune Suppression
(A) WT mice were treated with FITC with or without cutaneous Pam2Cys exposure following the protocol in Figure S1A. The mice were additionally treated with
Gr1 depleting (right) or with an isotype control antibody (left) at day 2 and 4. Ear swelling response (mean ± SD, n = 5, left) was evaluated. Data are representative
of two independent experiments.
(B and C) WT mice were treated following the protocol shown in Figure S1A (without Pam2Cys exposure). One group of mice received Ly6C-Ly6G positive cells
from donors that were sensitized with FITC and exposed to Pam2Cys. The control group received spleen cells from naive mice. The ear swelling response
(mean ± SD, n = 5) (B) and the FITC-specific proliferation of LN cells (as cpm, mean ± SD of triplicates) (C) were evaluated.
(D) CD11b+ cells of PBMCs from healthy volunteers (n = 8, left) and AD patients (n = 7, right) were depleted, and remaining PBMCswere stimulatedwith anti-CD3-
CD28-mAbs, and analyzed for proliferation. *p < 0.05 (Mann-Whitney test).
(E) PBMCs from healthy donors (n = 8) and AD patients (n = 7) were analyzed for TCR z-chain expression (mean fluorescence intensity [MFI], CD3+ gate of living
cells) by intracellular flow cytometry. Each dot represents an individual value, and the horizontal bar is the group’s mean. *p < 0.05 (Mann-Whitney test). See also
Figure S2.
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Figure 4. Skin Infection-Induced MDSCs Accumulate in the Skin in Mice and Humans
(A) WTmice were treated following the protocol in Figure S1A. The percentage of CD4+, CD8+, or Gr1+CD11b+ cells in Pam2Cys-exposedmice were analyzed by
flow cytometry at indicated time points after Pam2Cys exposure in BM (left) and spleen (right) (mean ± SD, n = 3). Asterisks show significant differences compared
with t = 0 determined by one-way ANOVA followed by Dunnett’s post test. *p < 0.05. Data are representative of two independent experiments.
(B) Cells from ear skin, isolated 4 hr or 8 hr after FITC challenge, were analyzed by flow cytometry (gate: living cells). A representative flow cytometry plot (left),
means ± SD (n = 5) (middle), and total numbers of Gr1+CD11b+ cells (mean ± SD, n = 5) (right) are shown. Data are representative of three independent experiments.
(C) Cells isolated from skin samples of AD patients (n = 9) and non-AD-controls (n = 9) were analyzed by flow cytometry (gate: living cells) for MDSCs, defined as
CD11b+CD33+HLA-DRCD14 cells. A representative flow cytometry plot with the gating strategy first for CD11b+CD14 (top) and then CD33+HLA-DR
(bottom) and the percentage of the CD11b+CD33+HLA-DRCD14 cells (left) and cumulative analysis (right) are shown. Each of the dots represents an individual
value and the horizontal bar the group’s mean. *p < 0.05 (Mann-Whitney test). n.s., not significant.
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Figure 5. Skin Infection-Induced MDSCs Suppress T Cell Activation through Mechanisms Requiring NO Production
(A) WT mice were treated following the protocol in Figure S1A. 24 hr (A and B) or 8 hr (C and D) after FITC challenge ear tissue cells were analyzed. (A) Flow
cytometry for CD3+ cells (left) and IFN-g production (right). A cumulative result (means ± SD, n = 5) is shown.
(B andC) Quantitative RT-PCR analysis for cytokines (B) or chemokines (C) (normalized to housekeeping genesActb-Gapdh) andmeans ± SEM (n = 5) are shown.
Expression of the skin of FITC only-exposed mice was set as 1. *p < 0.05.
(D) Cells isolated from BM, blood, and skin of Pam2Cys-treated mice were analyzed for chemokine receptor expression by flow cytometry (gate: Gr1+CD11b+ of
living cells), shown as percentage of Gr1+CD11b+ (means ± SD, n = 5).
(E) Spleen cells were cocultured in vitro with Ly6C+ or Ly6G+ MDSCs as indicated, stimulated by anti-CD3-CD28-mAbs and analyzed for proliferation (left);
supernatants (ratio 2:1) were analyzed for NO production by Griess reaction (mean ± SD of experimental triplicates) (middle), and iNOS inhibitors L-NMMA and
(legend continued on next page)
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addition, the inhibition of iNOS by L-NMMA or L-NIL completely
abrogated MDSC-mediated suppression of T cell proliferation
(Figure 5E, right). Similarly, in PBMCs of AD patients we detected
a distinct iNOS+ population of CD11b+CD11c- cells. These cells
were completely absent in healthy individuals (Figure 5F). Impor-
tantly, we also detected iNOS+CD11b+CD11c cells in AD skin
(Figure 5G, Figure S2H).
All together, the above results indicate that skin-infection-
induced MDSCs are present in the skin in mice and humans,
where they inhibit T cell proliferation bymeans of cell-to-cell con-
tact and iNOS.
Pam2Cys-Induced Immune Suppression Is Dependent
on Cutaneous TLR2
Next, we investigated underlying mechanisms how innate im-
mune sensing in the skin initiates MDSCs. Therefore we deter-
mined the role of TLR2. Tlr2/ and WT mice were treated as
shown in Figure S1A with or without cutaneous Pam2Cys
exposure. In contrast to WT mice (Figure 6A, left), Tlr2/ mice
failed to inhibit FITC-specific CHS (Figure 6A right) and T cell
proliferation (Figure 6B), and no reduction of CD4+ and CD8+
T cell numbers and accumulation of MDSCs (Figure 6C) was
observed following Pam2Cys exposure. Cutaneous innate
immune sensing through TLR2 might act through skin resident
cells or recruited circulating blood immune cells. Thus, mouse
chimeras were generated to distinguish between TLR2 sensing
of skin resident or recruited hematopoietic cells, as depicted
in Figure S3A.Chimerismwas confirmedbyPCRofBMcells (Fig-
ure S3B). The percentage of MDSCs was analyzed following the
protocol shown in Figure S1A. WT mice, reconstituted with WT
BM cells (WT +WT-BM) andWTmice, reconstituted with Tlr2/
BM cells (WT + Tlr2/-BM), upregulated MDSCs following
Pam2Cys exposure (Figure 6D, top). In contrast, Tlr2/mice re-
constituted with WT BM (Tlr2/ + WT-BM) failed to accumulate
MDSCs, similar to control Tlr2/mice with Tlr2/BM (Tlr2/ +
Tlr2/-BM) (Figure 6D, bottom). Thus, TLR2 expression on
skin-resident cells, which next to keratinocytes includes radia-
tion-resistant skin-resident Langerhans or mast cells, is neces-
sary and sufficient for MDSC accumulation.
Next, we investigated a functional role of TLR2 on MDSCs.
Chimeric mice were generated by reconstitution with 50%
CD45.1 WT and 50% CD45.2-Tlr2/ BM (Figure S3C).
Following Pam2Cys exposure, approximately 20% of spleen
cells were MDSCs irrespective whether WT CD45.1 or Tlr2/
CD45.2 cells were analyzed (Figure S3D), demonstrating that
TLR2 is dispensable on MDSC precursor cells for MDSC induc-
tion and accumulation.
Cutaneous IL-6 Is Critically Required for MDSC
Induction
Our previous experiments showed that cutaneous Pam2Cys
sensing through TLR2 is sufficient to induce MDSCs and
consecutive suppression of cutaneous recall responses.
To identify underlying mechanisms, we first analyzed which
cells in the skin could be responsible for sensing Pam2Cys.
Immunofluorescence staining of TLRs after exposure of
mice to Pam2Cys or Pam3Cys showed an upregulation of
the corresponding TLR on keratinocytes (Figure 7A). Similar
analyses of human skin samples showed pronounced TLR2
expression in human skin albeit at lower amount in AD
compared to healthy skin (Figure S4A), as known from other
studies (Kuo et al., 2013). Next, we analyzed the functional
consequences of the TLR upregulation. We exposed mice
to different TLR ligands (Pam2Cys, Pam3Cys, CpG, and
LPS) and analyzed cutaneous mRNA expression of cutaneous
cytokines. All TLR ligands moderately upregulated Tnf and
the chemokine Cxcl2 was most dominantly induced by
Pam2Cys and Pam3Cys (Figure 7B). Upregulation of Il6
mRNA in the skin was most pronounced only after Pam2Cys
exposure. In comparison to skin following FITC-only or
FITC-plus-other TLR-ligands exposure, cutaneous Pam2Cys
exposure induced a 400-fold upregulation of Il6 mRNA (Fig-
ure 7B, right). On the protein level, we detected increased
IL-6 production by CD45 negative cells (which were also
MHC-II negative, Figure S4B) (Figure 7C). To confirm these
data, we stimulated primary human keratinocytes with TLR
ligands and detected upregulation of IL-6 production exclu-
sively following Pam2Cys treatment (Figure 7D).
To regulate MDSC induction in the bone marrow (Figure 4A),
cutaneous IL-6 needs to reach the bloodstream (Chalmin et al.,
2010). Indeed, IL-6 concentrations in mouse sera strongly
increased 1 day after cutaneous Pam2Cys exposure (Figure 7E).
These data suggest that IL-6 plays a crucial role in Pam2Cys-
induced MDSC induction; therefore, Il6/ mice were investi-
gated. In contrast to WT mice, cutaneous Pam2Cys exposure
in Il6/ mice failed to suppress FITC-CHS (Figure 7F), and
no induction of MDSCs could be detected (Figure 7G). Conse-
quently, the injection of IL-6 into the mice caused an increase
of MDSCs in the spleen (Figures S4C and S4D), suggesting
that IL-6 is responsible for MDSC induction and expansion.
To investigate whether IL-6 plays a role in MDSC migration to
the skin, we applied anti-IL-6 antibody shortly before challenge
and analyzed MDSC numbers in the skin. We found a sig-
nificant and unequivocal increase of Gr1+CD11b+ cells in
both conditions (Figure S4E), and the adoptive transfer of
MDSCs into Il6/ mice showed a suppression of immune re-
sponses, comparable to what is observed in WT mice (Fig-
ure S4F). To investigate whether IL-6 plays a role for MDSC
development, we analyzed MDSCs generation in vitro. BM-
derived MDSCs (see Supplemental Experimental Procedures)
were treated with IL-6 during development, and their suppres-
sive function was investigated in a suppression assay with
responder cells. As shown in Figure 7H, the exposure of
MDSCs to IL-6 during generation enhanced their suppressive
L-NIL were added to the coculture (right). Significant differences between experimental conditions were assessed by one-way ANOVA followed by Tukey’s
post-hoc test (*p < 0.05). Data are representative of at least two independent experiments.
(F) PBMCs from healthy donors and AD patients were analyzed by intracellular flow cytometry (iNOS+ in CD11b+CD11c Gate of living cells). A representative
result out of seven individuals is shown.
(G) Skin tissue of AD patients was analyzed by immunofluorescence. Arrows indicate cells positive for CD11b and iNOS and negative for CD11c. Scale bar
represents 25 mm. See also Figure S2.
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function. These data indicate that IL-6 supports induction and
development of suppressive MDSCs, but not their migration
to the skin.
Taken together, these data suggest a scenario in which
Pam2Cys is sensed by TLR2 on skin resident cells, leading to
the expression and secretion of IL-6 in such high amounts that
Figure 6. Pam2Cys-Induced Immune Suppression Is Dependent on TLR2
(A–C) WT and Tlr2/mice were treated following the protocol shown in Figure S1A and ear swelling (mean ± SD, n = 5) after FITC challenge (A), proliferation of
lymph node cells after FITC stimulation ex vivo (mean ± SD of triplicates) (B), and the percentage of spleen cell populations (mean ± SD, n = 5) (C) were analyzed.
(D)WT or Tlr2/mice were irradiated and reconstitutedwithWT or Tlr2/BMcells (see Figure S3A). Seven weeks later, the chimericmicewere treated following
the protocol shown in Figure S1A and their spleen cells were analyzed by flow cytometry. The percentage of Gr1+CD11b+ cells is shown (mean ± SD, n = 5). Data
are representative of three independent experiments. *p < 0.05, n.s., not significant. See also Figure S3.
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MDSCs expand and accumulate, leading to the inhibition of
cutaneous recall responses.
DISCUSSION
In this study, we found that cutaneous exposure to bacteria and
bacterial substances known to act as potent MAMPs induced a
strong immune suppression mediated by MDSCs. These find-
ings highlight that certain classes of bacterial molecules are
able to orchestrate unique pathways that, even after limited
cutaneous exposure, are sufficient to induce immune suppres-
sion. We found that cutaneous exposure to TLR2-TLR6 but not
to TLR2-TLR1 ligands induced MDSCs and consecutive cuta-
neous immune suppression. Bacteria differ in the acylation pat-
terns of their lipoproteins (Kurokawa et al., 2012b). Our results
suggest that they might differ in their potential to activate
different TLR2 heterodimers and to regulate immune responses
as well. Consequently, acylation properties might characterize
bacteria as pathogens or commensals. It was shown recently
that the degree of lipoprotein-acylation depends on environ-
mental factors and growth phase. Lipoprotein SitC was triacy-
lated when S. aureus was in the exponential growth phase at
neutral pH and diacylated in the postexponential phase at low
pH (Kurokawa et al., 2012a). At the situation on the skin, where
pH is low and chronic S. aureus colonization (which is almost
always found in AD) is present, a postexponential growth
phase of S. aureus can be assumed. Consequently, lipoproteins
from S. aureus on the skin are more diacylated. On the basis
of our data and also own recently published data (Kaesler
et al., 2014), we hypothesize that diacylation of lipoproteins
induces acute inflammation followed by immune suppression
as a consequence. Further, one can also assume that patho-
genic and nonpathogenic skin microflora might have different
acylation properties and therefore different compositions of
TLR2 ligands and thus overall differ in regard to their immune
consequences.
Previous data obtained using a systemic sepsis model with
Gram-negative bacteria derived from the gut described the
MyD88 and TLR4 pathway to be most relevant for MDSC expan-
sion (Delano et al., 2007). However, the exact cascade of events
was not investigated (Arora et al., 2010; Delano et al., 2007). Our
data investigating the common route of cutaneous infection with
Gram-positive bacteria show that TLR2 activation on skin-resi-
dent cells mediates MDSC accumulation and consecutive
immune suppression. Induction of MDSCs by activation of cuta-
neous TLR2-6 most dominantly involves IL-6. Cutaneous innate
immune cells (Blander and Medzhitov, 2004), keratinocytes, and
evenmelanocytes (Stadnyk, 1994; Takashima and Bergstresser,
1996) are all capable of producing innate cytokines, such as IL-6.
Indeed, in AD, where keratinocytes act as a critical first line of
defense against microbes, early IL-6 production has been
described after direct contact of keratinocytes with S. aureus
(Sasaki et al., 2003). Moreover, IL-6 has been found to be
increased in AD skin (Fedenko et al., 2011) and especially in
AD skin lesions (Travers et al., 2010), in which the amount of
IL-6 correlates with bacterial burden (Travers et al., 2010).
Genome-wide association studies recently also identified an
IL-6 receptor (IL-6R) variant as a risk factor for AD (Esparza-Gor-
dillo et al., 2013) and a small case series with three patients has
demonstrated therapeutic efficacy of an IL-6R blockade by toci-
lizumab, an IL-6R antibody (Navarini et al., 2011). These obser-
vations confirm the importance of IL-6 production by skin cells
in response to microbes; however, the precise immune conse-
quences of cutaneous IL-6 induction had not been elucidated.
Our data allow us to propose a model of how the cutaneous
innate immune network functions: diacylated lipopeptides acti-
vate TLR2-TLR6 on skin resident cells followed by marked IL-6
production leading to the MDSC accumulation, which is a pre-
requisite of subsequent immune suppression by MDSCs. Our
data also indicate that these TLR2-6-induced MDSCs are proto-
typic MDSCs as characterized in other settings. Moreover, our
data have further identified that skin-infection-induced MDSCs
suppressed immune responses in mice and humans.
In conclusion, our study reveals a consequence of cutaneous
innate immune sensing for adaptive immune functions. The pres-
ence of certain lipoproteins on the skin might serve not only as
danger signal for the initiation of effective immune responses
but also might be able to counterregulate inflammation and
potently control and suppress immune responses.
EXPERIMENTAL PROCEDURES
Animals
Specific-pathogen-free, WT BALB/cmice were purchased fromCharles River.
Tlr2/ mice (C57BL/6) were from C. Kirschning (Institute of Medical Microbi-
ology, University Duisburg-Essen) and were backcrossed to BALB/c for ten
generations. Il6/-BALB/c mice were from Dr. M. Kopf (Swiss Federal Insti-
tute of Technology). All mice were kept under specific pathogen-free condi-
tions in accordance with FELASA (Federation of European Laboratory Science
Association) in the University of Tu¨bingen. The experiments were performed
with the approval of the local authorities (Regierungspra¨sidium Tu¨bingen
HT1/10, HT3/11, HT7/11, HT5/13, HT8/13). Age-matched female mice were
used in all experiments.
Epicutaneous Mouse Skin Infection Model
The experimental model is based on epicutaneous application of the S. aureus
on shaved skin of mice (Wanke et al., 2013). Mice were sensitized with FITC
following the protocol as shown in Figure S1A. At days 7 and 10 3 3 108 WT
or lgt mutant S. aureus Newman in 30 ml PBS or PBS control were added to
filter paper discs placed onto the prepared skin and covered by Finn Cham-
bers on Scanpor (Smart Practice). Before application to the skin, barrier was
disrupted by tape stripping.
FITC Contact Hypersensitivity and Exposure to TLR2 Ligands
Mice were sensitized by administration of 80 ml of a 0.37% FITC solution
(dissolved in 1:1 acetone:dibutyl phthalate, Sigma Aldrich) on the shaved
abdomen on days 8 and 7. TLR2 ligands were applied intracutaneously
together with the second epicutaneous application of FITC on days 1 and
0 (Figure S1A) in the following concentrations per mouse: Pam2Cys, 2 mg;
Pam3Cys, 4 mg; FSL-1, 40 mg. Control mice obtained PBS instead of TLR2
ligands. At day 7, mice were challenged by epicutaneous application of
0.37% FITC solution on both sides of the ears. Ear thickness was mea-
sured with a micrometer (Oditest) as previously described (Volz et al., 2014),
and data are expressed as change in ear thickness compared to thickness
before treatment. In some experiments, mice were treated with 0.3 mM CpG
1668 (0.2 mM, Eurofins Genomics), 1 mg/mouse LPS (from Salmonella
minnesota R595, Alexis Biochemicals), cyclophoshamide (2 mg/mouse,
Sigma-Aldrich), 20 mg/mouse rmIL-6 (20 mg/mouse) or 50 mg/mouse anti-
IL-6 (BioLegend).
Human MDSCs
The study was approved by the local ethics committee of the University of Tu¨-
bingen, Germany, and written informed consent was obtained from all
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Figure 7. IL-6 Is Required for Induction of Gr1+CD11b+ Cells and Pam2Cys-Induced Immune Suppression
(A–C) WT mice were treated following a protocol similar to that shown in Figure S1A. 24 hr after cutaneous exposure to TLR ligands or PBS (control), immu-
nofluorescence for TLR2 (red), TLR6 or TLR1 (blue), and nuclei (green) was done in (A), a representative picture (n = 3) is shown. Scale bar represents 30 mm (B).
The skin was evaluated for the expression of Tnf, Cxcl2, and Il6mRNA by quantitative RT-PCR analysis (normalized to housekeeping gene Actb). Expression in
the skin of untreated mice (naive) was set as 1 (mean ± SD, n = 5). (C) Skin cells were isolated and analyzed for IL-6 production by intracellular flow cytometry, and
a cumulative analysis (mean ± SD, n = 5) is shown.
(D) Primary human keratinocytes were isolated and treated with TLR ligands for 24 hr, and the production of IL-6 was measured by ELISA (mean ± SD of trip-
licates).
(legend continued on next page)
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subjects (project number 344/2011BO2, 345/2011BO2, 396/2011BO2, 040/
2013BO2, 180/2013BO2). PBMCs were obtained from heparinized blood by
centrifugation (800 g for 30 min) using Ficoll-Histopaque (Biochrom). MDSCs
in the blood or skin of either healthy volunteers or non-AD-controls or atopic
dermatitis patients were analyzed by flow cytometry and characterized as
CD11b+CD33+HLA-DRCD14 cells.
Bone-Marrow Chimeras
Recipient mice were lethally irradiated at 7.0 cGy and on the next day BM cells
(106 cells per recipient) were intravenously injected into recipient mice. To
confirm the chimerism of mice, we conducted genotyping of BM cells by
PCR for the WT and the mutated Tlr2 gene (Figure S3B).
Depletion of CD11b+ Cells
CD11b+ cells were depleted from PBMCs using the CD11b+ Beads (Miltenyi
Biotech) according to the manufacturer’s protocol.
Statistical Analysis
Unless otherwise stated, quantitative results are expressed as means ± SD
and differences were compared by unpaired, two-tailed Student’s t test (p <
0.05 was regarded as significant).
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Figure S1. Cutaneous exposure to bacterial lipoproteins induces immune suppression 
(related to Figure 1).
(A) Protocol of FITC-CHS with and without cutaneous exposure to S. aureus or TLR ligands. 
Wild-type (WT) mice were sensitized by administration of FITC solution on the shaved abdomen 
on days -8 and -7. Together with the second application of FITC on days -1 and 0, some mice 
were epicutaneously exposed to living WT or lipoprotein deficient (lgt) S. aureus or TLR 
ligands in addition. Control mice obtained phosphate-buffered saline (PBS). As read out for the 
cutaneous recall immune response, FITC was applied to the previously untreated ear skin on 
day 7 and the increase of ear thickness (ear swelling) was measured over a period of 3 days. 
(B) WT mice were treated following a protocol similar to that shown in Figure S1A in which mice 
were sensitized by administration of FITC solution on the shaved abdomen on days -8, -7. On 
days -1 and 0 living WT or lipoprotein deficient (lgt) S. aureus was applied intracutaneously
together with the second cutaneous application of FITC. Ear swelling was recorded following a 
FITC challenge on ear skin five days later (mean +/- SD, n=5). Data are representative of two 
independent experiments. 
(C-I) FITC-sensitized WT mice were treated following the protocol in Figure S1A (epicutaneous
exposure to WT or lipoprotein-deficient lgt S. aureus in C-F and to Pam2Cys in G-I). C-F) 
Bacterial load as colony forming units (CFU) (C), cell populations in the liver (D) and in draining 
lymph nodes (E, F) 3 days after FITC challenge were investigated (mean +/- SD, n=5). (G-I)  
Draining (axillary and inguinal) and non-draining (retroauricular) lymph nodes (LN) were 
collected at 14 h after the last treatment with FITC and Pam2Cys exposure (14 h after d1 in 
Figure S1A) and different cell populations were analyzed by flow cytometry . (G) A 
representative flow cytometry plot (left), means +/- SD (n=5) (middle) of MHC-II+FITC+
(CD11c+-Gate), means +/- SD (n=5) of dDCs (CD11chiCD205lo) and LC (CD11cloCD205hi) (right) 
and other cell populations (as a percentage of living cells) (H, I) are shown (mean +/- SD, n=5). 
(J-L) WT mice were treated with FITC with or without cutaneous Pam2Cys exposure following 
the protocol in Figure S1A. Some mice were treated with 2mg cyclophosphamide (Cy) at d7 for 
Treg cell depletion. Ear swelling after FITC challenge (mean +/- SD, n=5) (J), proliferation of 
skin-draining lymph node cells stimulated ex vivo with FITC (cpm, mean +/- SD of triplicates) (K) 
and the percentage of cell populations in the spleen (mean +/- SD, n=5) (L) were investigated. *: 
P < 0.05 (unpaired, two-tailed Student’s t-test).
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Figure S2. Myeloid-derived suppressor cells are responsible for Pam2Cys-induced 
immune suppression (related to Figure 3 and Figure 5). 
(A-G) WT mice were treated with FITC with cutaneous Pam2Cys exposure following the 
protocol in Figure S1A. (A) 14h after FITC challenge, skin cells of the ears were isolated, 
CD11b+ cells (n=5, right) depleted or not, stimulated with anti-CD3-CD28-mAbs and analyzed 
for proliferation (as cpm, mean +/- SD, n=5). *: P < 0.05 (unpaired, two-tailed Student’s t-
test). (B-D) Gr-1dimLy6G-Ly6C+CD11b+ (Ly6C+) and Gr-1highLy6G+CD11b+ (Ly6G+) cells were 
isolated 10 days after Pam2Cys exposure by MACS from spleens of Pam2Cys-exposed 
mice. Afterwards cytospin preparations were made from splenic MDSCs and the morphology 
was analyzed by histological staining (May-Grünwald-Giemsa) in (B). Original magnification 
was x100, representative images are shown. (C) The phenotype of the Gr1+CD11b+ cells 
(skin, 14 h after FITC challenge from Pam2Cys-treated mice) or suppressive Ly6C+ MDSCs
(spleen) was analyzed for surface marker expression by flow cytometry as indicated (gated 
for Gr1+CD11b+ cells in the skin and Ly6C+Ly6G-cells in the spleen). One representative 
result is shown. (D) Polarized T cells were co-cultured in vitro with Ly6C+ MDSCs as 
indicated, stimulated by anti-CD3-CD28-mAbs and analyzed for proliferation. (E) 8 h after the 
FITC challenge ear skin cells were analyzed for Nos2 expression by qRT-PCR (normalized to 
housekeeping genes -actin-GAPDH), mean +/- SEM (right, n=5) is shown. Expression of the 
skin of FITC only-exposed mice was set as 1. (F) Proliferation of anti-CD3-CD28-mAbs 
stimulated spleen cells was measured with or without the addition of Ly6C+ cells (ratio 2:1) 
(black and white bars, respectively) or in the presence of a transwell membrane (grey bars). 
Results are expressed as mean +/- SD of experimental triplicates. Significant differences 
between experimental conditions were assessed by one-way ANOVA followed by Tukey’s
post hoc test (*: P < 0.05). (G) Gr1+ cells of the coculture of (F) were stained for iNOS, 
Arginase and IL-10 by intracelullar flow cytometry (Gate for Gr1+ cells). 
(H) Skin tissue of AD patients was analyzed by immunofluorescence staining for CD11b 
(red), CD11c (white) and iNOS (green) and visualized by confocal microscopy. Arrows 
indicate cells positive for CD11b and iNOS and negative for CD11c. Scale bar represents 
25 m.
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Figure S3. Pam2Cys-induced immune suppression is dependent on TLR2 (related to 
Figure 6). 
(A) Protocol for the generation of chimeric mice. WT mice were irradiated and reconstituted with 
WT or Tlr2-/- bone marrow (BM) cells. 7 weeks later, the mice were treated following the protocol 
shown in Figure S1A. 
(B) To confirm the chimerism of mice, genotyping of BM cells by PCR for the WT and the 
mutated TLR2 gene was conducted. 
(C) Protocol for the generation of chimera-mix mice. WT mice were irradiated and reconstituted 
with BM consisting of 50% of CD45.1+ wild-type and 50% CD45.2+ Tlr2-/- cells. 7 weeks later, the 
mice were treated following the protocol shown in Figure S1A. 
(D) Chimera-mix mice were generated. Representative flow cytometry histograms are shown. 
Gray filled line: isotype control, black line: respective CD45 allele stain (left, top). Spleen cells 
were isolated and analyzed by flow cytometry. The percentage of Gr1+CD11b+ cells in the 
spleens is shown as a representative flow cytometry plot (left, bottom) or quantification (mean 
+/- SD, n=10) (right). Data are representative of three independent experiments. *: P < 0.05 
(unpaired, two-tailed Student’s t test). n.s., not significant.
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Figure S4. Skin-derived IL-6 is required for induction of Gr1+CD11b+ cells, but not needed 
for MDSC migration to the skin and for the suppressive function of developed MDSCs
(related to Figure 7). 
(A) Skin tissue of AD patients from Figure 4C was analyzed by immunofluorescence staining for 
TLR2 and visualized by confocal microscopy. A cumulative analysis of mean fluorescence 
intensity, MFI (mean +/- SD, n=8) is shown. *: P < 0.05 (Mann-Whitney test). 
(B-E) WT mice were treated following a protocol similar to that shown in Figure S1A (with 
Pam2Cys treatment).(B) 24 h after cutaneous exposure to PBS (control), Pam2Cys or 
Pam3Cys, skin cells were isolated and analyzed for IL-6 production by intracelullar flow 
cytometry (gate: living cells), a cumulative analysis (mean +/- SD, n=5) is shown. (C, D) Some 
mice were exposed to a lower dose of Pam2Cys (1/3 of dose); some mice were treated with 
20µg rmIL-6 at d 7 and d 8 of the protocol. Ear swelling after FITC challenge (C) and the 
percentage of cell populations in the spleen (D) (mean +/- SD, n=5) were analyzed. (E) 2 h 
before FITC challenge one group of mice was treated i.p. with anti-IL-6 (50µg/mouse). 8 h after 
FITC challenge cells were isolated from ear skin and the percentage of Gr1+CD11b+ cells was 
analyzed by flow cytometry. A cumulative result (mean +/- SD, n=5) is shown. 
(F) WT and Il6-/- mice were treated following the protocol shown in Figure S1A (without 
Pam2Cys exposure). One group of mice received Ly6C-Ly6G positive cells from donors that 
were sensitized with FITC and exposed to Pam2Cys. The control group received spleen cells 
from naïve mice (see Methods, adoptive transfer). The ear swelling response after FITC 
challenge (mean +/- SD, n=5) is shown. *: P < 0.05 (unpaired, two-tailed Student’s t test).
Supplemental Experimental Procedures 
Quantitative real-time PCR 
Total RNA was extracted with peqGOLD total RNA Kit (Peqlab, Erlangen, Germany) and 
reverse-transcribed to cDNA with iScript cDNA Synthesis Kit (Bio-Rad, München, 
Germany). The real-time PCR assay was carried out with Light-Cycler LC480 (Roche, Basel, 
Switzerland). Data are presented as normalized to housekeeping genes -actin and GAPDH.  
Primer Sequence forward Sequence reverse 
Actb CTGAAGCAGCTATGGCAACT GGATGCTCTCATCTGGACAG 
Gapdh TGGAGAAACCTGCCAAGTATG GTTGAAGTCGCAGGAGACAAC 
Tnf CTGTAGCCCACGTCGTAGC TGGAGATCCATGCCGTTG 
Cxcl2 CCAGACTCCAGCCACACTTC AGGGTCTTCAGGCATTGACA 
Il6 GCTACCAAACTGGATATAATCAGGA CCAGGTAGCTATGGTACTCCAGAA 
Ifn ATCTGGAGGAACTGGCAAAA TTCAAGACTTCAAAGAGTCTGAGGTA 
Il4 TCAACCCCCAGCTAGTTGTC TGTTCTTCGTTGCTGTGAGG 
Il10 TGGGTGAGAAGCTGAAGACC TGGCCTTGTAGACACCTT 
Il17 AACCGATCCACCTCACCTT GGCACTTTGCCTCCCAGAT 
Ccl2 GGACCCATTCCTTCTTGG ACAAGAGGATCACCAGCAGC 
Ccl3 CCTGCTCAACATCATGAAGGTCTC GGTCAGTGATGTATTCTTGGACC 
Ccl4 AACCCCGAGCAACACCATGAAG CCACAATAGCAGAGAAACAGCAAT 
Ccl5 TCCTTCGAGTGACAAACACGA TGCTGCTTTGCCTACCTCTC 
Ccl11 TCCACAGCGCTTCTATTCCT CTATGGCTTTCAGGGTGCAT 
Ccl13 GGTGGTGTTGAGTCTAGA GCACATATGAGGAGATTCGG 
Ccl17 AGTGGAGTGTTCCAGGGATG CTGGTCACAGGCCGTTTTAT 
Ccl20 CGACTGTTGCCTCTCGTACA AGGAGGTTCACAGCCCTTTT 
Ccl22 GTCCTAGGGAGGAGGACCTG GAAGGGGGATAAGCTGGAAG 
Ccl27 CTCCCGCTGTTACTGTTGCT TCTGGGGATGAACACAGACA 
Ccl28 TGGCAAAAGCCACATTCATA CATGCCAGAGTCGAACAGAA 
 
  
Immunofluorescence staining 
For staining of human samples, primary antibodies (rabbit a-human CD11b (Life Span, 
Seattle, USA), mouse IgG1 a-human iNOS, rabbit polyclonal a-human TLR2 (Abcam, 
Cambridge, United Kingdom), mouse IgG2a a-human CD11c (Novocastra, Wetzlar, 
Germany) were applied to deparaffinized sections at room temperature. After washing, 
fluorescence-labelled secondary antibodies (goat F(ab')2 a-rabbit-IgG-AF546, goat a-mouse-
IgG1-AF647, goat F(ab')2 a-mouse-IgG2a-AF488 (Life Technologies, Darmstadt, Germany))  
were applied. Sections were mounted with DAPI (4,6 diamidino-2-phenylindole)-containing 
medium (Vector Laboratories Inc., Burlingame, USA). Stained sections were examined under 
a LSM confocal microscope (Zeiss, Jena, Germany). 
For staining of mouse skin, Pam2, Pam3 or PBS was injected into the skin and 24 h later 
epidermis was cryofixed in liquid nitrogen, and 5-µm sections were placed on Silane-Prep 
slides (Sigma-Aldrich Chemie GmbH, München, Germany). Sections were fixed in 
periodate–lysine–paraformaldehyde (paraformaldehyde and lysine in PBS) for 2 minutes, 
followed by incubation with PBS for 5 minutes, PBS/BSA (0.1%) plus Tween 20 (0.1%) for 5 
minutes, and PBS plus 10% donkey serum for 30 minutes at room temperature. Anti TLR2  
monoclonal rat antibody (1:50), anti-TLR1 or TLR6 polyclonal rabbit antibodies (1:100) 
(Abcam, Cambridge, Great Britain) were added for 60 minutes at room temperature. Sections 
were then incubated with donkey anti-rat–Dylight 549 or donkey anti-rabbit–Dylight 649 
(1:800; Dianova,Hamburg, Germany)  for 60 minutes. All nuclei were stained with YOPRO 
(Invitrogen, Darmstadt, Germany). All washing and antibody addition steps were performed 
with a combination of PBS, BSA, and Tween. The sections were analyzed with a confocal 
laser scanning microscope (Leica TCS SP; Leica Microsystems) at 630 magnification. 
Isolation of Gr1+CD11b+ cells 
Gr-1dimLy6G-Ly6C+CD11b+ and Gr-1highLy-6G+CD11b+ cells were isolated from spleens 
using the MDSCs Isolation Kit (Miltenyi Biotech, Bergisch Gladbach, Germany) according to 
  
manufacturer’s protocol. Purity was routinely more than 90% as assessed by flow cytometry 
analysis. 
Gr-1 depletion 
200µg/mouse of Ly6G depleting antibody (eBioscience, San Diego, USA) or isotype control 
was injected to mice i.p. at day 3 and 5 of the protocol shown in Figure S1A.  
Skin cell analysis 
Skin cell suspensions were generated by incubating skin tissue with dispase-II (Sigma-
Aldrich, Taufkirchen, Germany) overnight at 4°C. Afterwards the human skin was incubated 
in collagenase A (Serva, Heidelberg, Germany) for 30 min at 37°C and then homogenized by 
GentleMACS (Miltenyi, Biotech, Bergisch Gladbach, Germany). Dermis and epidermis of 
mice skin was separated and incubated in collagenase A (Serva, Heidelberg, Germany) or 
trypsin-EDTA (Biochrom Berlin, Germany), respectively, for 30 min at 37°C for the 
digestion. Afterwards the obtained cell suspensions of epidermis and dermis were pooled, 
washed twice and analyzed by flow cytometry. For intracellular flow cytometry, ear skin 
tissue was incubated with Brefeldin A (Sigma-Aldrich, Taufkirchen, Germany) (20 µg/ml) for 
2h at 37°C. 
Bone marrow-derived MDSCs 
BM cells were isolated from naïve BALB/c mice and cultured in medium with 20ng/ml GM-
CSF (R&D Systems, Minneapolis, USA) for 4 days. Afterwards the cells were harvested and 
cocultured with spleen cells (ratio 1:4), activated with anti-CD3 (2µg/ml)/anti-CD28 (1µg/ml) 
for proliferation. Proliferation was evaluated by 3H-thymidine incorporation (as counts per 
minute, cpm) during the last 10 hours of culture. 
Bacteria preparation 
  
Following 1:100 dilution of an overnight culture in LB medium, Staphylococci were grown 
with shaking at 37°C to an optical density at 600 nm of 0.4-0.6. Culture aliquots were 
sedimented by centrifugation, and Staphylococci were washed and suspended in PBS.  
T cell proliferation assay 
Splenocytes from naïve BALB/c mice were cultured in the presence of 4 µg/ml anti-CD3 and 
2 µg/ml anti-CD28 (Biolegend, San Diego, USA). Gr-1dimLy6G-Ly6C+CD11b+ (Ly6C+) and 
Gr-1highLy-6G+CD11b+ (Ly6G+) cells were isolated from the spleens of Pam2Cys-exposed 
mice (protocol Figure S1A) and added to the cultures at different ratios. Proliferation was 
evaluated by 3H-thymidine incorporation (as counts per minute, cpm) during the last 10 hours 
of culture. For some assays iNOS inhibitors NG-Methyl-L-arginine acetate salt (L-NMMA, 
4mM, Sigma-Aldrich, Taufkirchen, Germany) and L-N6-(1-Iminoethyl)lysine 
dihydrochloride (L-NIL, 0.5mM, Sigma-Aldrich, Taufkirchen, Germany) were used. 
Adoptive transfer 
A total of 20 x 106 MDSCs (3-4 x 106 Ly6C+ and 16-17 x106 Ly6G+) from spleen or BM cells 
from Pam2Cys-exposed mice were injected i.v. into FITC-sensitized mice on days 2, 4, and 6. 
As controls, spleen or BM cells from naïve mice were transferred at the same time points. 
Primary human keratinocytes 
Primary human keratinocytes were isolated from foreskin. Epidermis was dissected from the 
dermis using dispase-II (Sigma-Aldrich, Taufkirchen, Germany) and cultured in keratinocyte 
medium (KGM2; PromoCell, Heidelberg, Germany) containing a supplement mix (5mg/l 
insulin, 0.1mM ethanolamine, 0.1 phosphoethanolamin, 5 x 10-7M hydrocortison (Sigma-
Aldrich, Taufkirchen, Germany), 100mg/l penicillin/streptomycin, 0.4µg/l EFG (Thermo 
Fisher Scientific Inc, Waltham, USA). To expand cell populations, keratinocytes were grown 
in low Ca2+ (0.06?mM). For experiments, the Ca2+ concentration was increased to 1.8?mM to 
promote differentiation.  
  
The generation of Newman lgt mutant 
The Newman lgt mutant was generated exactly as described in (Stoll et al., 2005) for 
SA113. For deletion of the lgt gene in the genome of S. aureus strain Newman, a 1-kb 
fragment including hprK was generated by PCR using Pwo polymerase (Hybaid). An EcoRI 
restriction site was introduced into the forward primer and a SmaI restriction site into the 
reverse primer. The fragment was subcloned into pUC18 digested with the same restriction 
enzymes, yielding pUC18hprK. A 1.1-kb fragment including the entire yvoF gene and the 5‘ 
end of the yvcD gene was amplified using SmaI and a BamHI restriction sites, respectively, 
and ligated into pUC18 hprK. The ermB gene from Tn551 was removed from pEC2 by 5‘ 
cleavage with XbaI and 3‘ cleavage with HindIII, the ends were filled in with Klenow 
enzyme, and ermB was blunt end ligated into the SmaI site between the hprK and yvoF genes 
in pUC18. The inserted fragments were sequenced and introduced into the temperature-
sensitive shuttle vector pBT2 harboring the Cmr marker gene cat. The resulting inactivation 
plasmids were designated pBT-lgt for and pBT-lgt rev. After construction in E. coli, the 
plasmids were separately electroporated into S. aureus RN4220, purified after selection of 
transformants on Cm-containing BM agar plates, and electroporated into S. aureus strain 
Newman. 
Insertional inactivation of lgt by homologous recombination was achieved as described in 
(Bruckner, 1997). Single Em-resistant and Cm-sensitive colonies were presumed to have 
undergone double crossover and were obtained from cultures harboring the pBTlgt for 
plasmid. The lgt::ermB genotype of two colonies was confirmed by PCR analysis and 
sequencing.  
Th polarized culture 
To prepare CD4+ polarized cells, CD4+CD62L+ T cells were purified from peripheral LN cells 
and spleen obtained from naïve BALB/c mice by negative selection using MACS beads 
(Miltenyi Biotech, Bergisch Gladbach, Germany). Cells were stimulated with 4µg/ml anti-
  
CD3 (Th17) or 4-2µg/ml anti-CD3-anti-CD28 (Th0, Th1, Th2). For Th1 polarizing conditions 
CpG 1668 (0.2µM, Eurofins Genomics, Ebersberg, Germany) and anti–IL-4 (1µg/ml, 
α11B11) were added at d0. For Th2 polarizing conditions IL-4 (50ng/ml, Promokine, 
Heidelberg, Germany), anti-IFN- (5µg/ml, Biolegend, San Diego, USA) were added at d0 
and d3. For Th17 polarizing conditions anti–IL-4 (1µg/ml), anti-IFN- (5µg/ml, Biolegend, 
San Diego, USA), TGF (2ng/ml, R&D Systems, Minneapolis, USA) and IL-6 (10ng/ml, 
Biolegend, San Diego, USA) were added at d0; at d4 the cells were restimulated with anti-
CD3 and IL-23 (10ng/ml, R&D Systems, Minneapolis, USA) was added. All T cell cultures 
were supplemented with IL-2 (5 ng/ml) for up to 8 days. Then, the cells were used for the 
coculture experiment with MDSCs. To prove polarization, the cells were stimulated with 
PMA/Ionomycin (Sigma Aldrich, Taufkirchen, Germany) in the presence of BD GolgiStop 
(BD Biosciences, Heidelberg, Germany), then the cells were stained for detection of 
intracellular cytokines. Supernatants after the stimulation were collected for ELISA. 
Flow cytometry 
Flow cytometry data were acquired using a LSRII flow cytometer (BD Biosciences, 
Heidelberg, Germany) and then analyzed using FCS Express V3 Software (De Novo 
Software, San Diego, USA). 
Antibodies: Antibody, Clone, Catalog number 
Mouse: 
B220-PE, RA3-6B2, BD Pharm. #553090 
CD11b-PB, M1/70, Biolegend #101224  
CD11b-FITC, M1/70, BD Pharm. #557396 
CD4-PB, RM4-5, BD Pharm. #558107 
CD8-FITC, 53-6.7, Biolegend #100706 
CD3 funct., 145-2C11, Biolegend #100314 
CD3-APC, 145-2C11, Biolegend #100312 
  
CD11c-APC, N418, Biolegend #117310 
CD13-FITC, R3-242, BD Pharm. #558744 
CD16/32 funct., FCR-4G8 
CD16/32-PE-Cy7, 93, eBiosc. #25-0161-82 
CD21/35-APC-Cy7, 7E9, Biolegend #123419 
CD28 funct., 37.51, Biolegend #102112 
CD45.1-PerCP, A20, BioLegend #110726 
CD45.2-PB, 104, Biolegend #109820 
CD115-PE, AFS98, Biolegend #135505 
F4/80-PE; BM8, BioLegend #123110 
Gr1-APC, RB6-8C5, Biolegend #108411 
IFNg-PE, XMG1.2, BD Pharm. #554412 
MHC-II-PE, M5/114.15.2, Biolegend #107608 
Ly-6G (Gr-1), Functional Grade Purified, RB6-8C5, eBioscience #16-5931-86  
CCR3-Alexa flour 647, J073E5, Biolegend #144507 
CCR4-APC, 2G12, Biolegend #131212 
CCR10-APC, 248918, R&D #FAB2815A 
IL-10-PE, JES5-16E3, BioLegend #505007 
Human: 
CD11b-PB, ICRF44, Biolegend #301316, Charles N, et al. 2010 
CD11c-APC, 3.9, Caltag, #MHCD11c05, Wimazal F, et al. 1999 
CD14-FITC, HCD14, Biolegend #325603, Séguier S, et al. 2013 
CD33-PE, WM53, Biolegend #303403, Pèrez-Oliva AB, et al. 2011 
HLA-DR-APC, L243, Biolegend #307609, Zaba LC, et al. 2007 
iNOS-FITC, polyclonal, Biorbyt #orb14179, Guo Z, et al. 2013 
 
  
References: 
 
Bruckner, R. (1997). Gene replacement in Staphylococcus carnosus and Staphylococcus 
xylosus. FEMS microbiology letters 151, 1-8. 
 
Stoll, H., Dengjel, J., Nerz, C., and Götz, F. (2005). Staphylococcus aureus deficient in 
lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun 73, 
2411-2423. 
 
 
 
